1 Top |
sICAM-1 (cis) Intercellular adhesion molecule 1 |
ICAM4abc, ICAM5ac, ICAM1ae, ZGLP1b, TYK2b [3 more]KRI1b, PPANb, P2RY11b |
rs5498 19:10,395,683 |
7.7×10-267 replicable replicated |
|
diagnosis, efficacy, prognosis, unspecified application |
1 |
sICAM-5 (cis) Intercellular adhesion molecule 5 |
ICAM4abc, ICAM5ac, ICAM1ae, ZGLP1b, TYK2b [3 more]KRI1b, PPANb, P2RY11b |
rs5498 19:10,395,683 |
2.4×10-32 replicable replicated |
|
|
2 Top |
IL-6 sRa (cis) Interleukin-6 receptor subunit alpha |
IL6Rabc, C1orf189b, UBAP2Lb, AQP10c, UBE2Q1c |
rs4129267 1:154,426,264 |
1.6×10-265 replicable replicated |
tocilizumab |
efficacy |
3 Top |
PPAC (cis) Low molecular weight phosphotyrosine protein phosphatase |
ACP1abce, SH3YL1abc, FAM150Ba |
rs11553746 2:272,203 |
1.1×10-257 replicable replicated |
|
|
4 Top |
MSP (cis) Hepatocyte growth factor-like protein |
MST1abce, AMTabc, APEHabc, BSNabe, GPX1ace [29 more]NICN1ac, DAG1ab, RNF123ac, UBA7bc, USP4bc, QRICH1bc, KLHDC8Bbc, CDHR4bc, RHOAa, TCTAa, ARIH2b, LAMB2b, IMPDH2b, DALRD3b, NDUFAF3b, SLC25A20b, IP6K1b, CAMKVb, QARSb, MON1Ab, TRAIPb, RBM6c, WDR6c, MST1Rc, IP6K2c, FAM212Ac, C3orf62c, CISHc, DOCK3c |
rs9858542 3:49,701,983 |
1.4×10-242 replicable replicated |
|
|
5 Top |
sLeptin R (cis) Leptin receptor |
LEPRae |
rs17415296 1:66,099,013 |
4.5×10-229 replicable replicated |
recombinant-methionyl human leptin |
prognosis |
6 Top |
IL-1 R AcP (cis) Interleukin-1 Receptor accessory protein |
IL1RAPa |
rs1024948 3:190,347,681 |
2.5×10-165 replicable replicated |
|
|
7 Top |
Siglec-3 (cis) Myeloid cell surface antigen CD33 |
CD33ace, SIGLEC12b, SIGLECL1c |
rs12459419 19:51,728,477 |
2.9×10-165 replicable replicated |
arsenic trioxide/gemtuzumab ozogamicin/tretinoin, gemtuzumab ozogamicin |
efficacy |
8 Top |
MAPKAPK3 (trans) MAP kinase-activated protein kinase 3 |
ZC3H13ae, CPB2ae, LCP1c |
rs1926447 13:46,629,944 |
2.2×10-145 replicable replicated |
|
unspecified application |
8 |
MIF (trans) Macrophage migration inhibitory factor |
ZC3H13ae, CPB2ae, LCP1c |
rs1926447 13:46,629,944 |
1×10-12 |
|
diagnosis, prognosis, response to therapy |
9 Top |
Cripto (cis) Teratocarcinoma-derived growth factor 1 |
LRRC2abc, TDGF1ac, PRSS50b, LTFb, CCR2b [1 more]ALS2CLc |
rs3806701 3:46,617,337 |
3.8×10-145 replicable replicated |
|
diagnosis |
10 Top |
FCG2A/B (cis) Low affinity immunoglobulin gamma Fc region receptor II-a/b |
FCGR2Bac, FCGR3Bc, FCRLBc |
rs17413015 1:161,644,811 |
9.2×10-137 replicable replicated |
|
|
11 Top |
ARTS1 (cis) Endoplasmic reticulum aminopeptidase 1 |
ERAP1ac, ERAP2c, LNPEPc |
rs26496 5:96,137,882 |
6.4×10-123 replicable replicated |
|
|
12 Top |
Gro-a (cis) Growth-regulated alpha protein |
CXCL1a, EREGb, MTHFD2Lb, CXCL6b, AFMb [1 more]PF4V1c |
rs3117600 4:74,731,812 |
3.2×10-120 replicable replicated |
|
disease progression |
13 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
MICAabc, VARS2b, PSORS1C2c, HLA-Cc, HLA-Bc [6 more]PSORS1C1c, ATP6V1G2c, HCG27c, LTAc, TAP2c, XXbac-BPG246D15.9c |
rs2844511 6:31,389,784 |
3.8×10-119 replicable replicated |
|
safety |
14 Top |
ARTS1 (cis) Endoplasmic reticulum aminopeptidase 1 |
ERAP1abce, CASTac, LIX1b, ERAP2b, LNPEPb |
rs17482078 5:96,118,866 |
3×10-115 replicable replicated |
|
|
15 Top |
PDGF Rb (cis) Platelet-derived growth factor receptor beta |
PDGFRBac, CDX1c, CSF1Rc |
rs3776081 5:149,532,107 |
3.3×10-113 replicable replicated |
nilotinib, dasatinib, sunitinib, pazopanib, axitinib, tivozanib, tandutinib, nintedanib, regorafenib, bortezomib/sorafenib, lapatinib/pazopanib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, imatinib/sirolimus, imatinib, sorafenib, becaplermin |
prognosis, response to therapy, unspecified application |
16 Top |
FCG2A/B (cis) Low affinity immunoglobulin gamma Fc region receptor II-a/b |
FCGR2Aabe, SDHCc |
rs7551957 1:161,470,042 |
2.2×10-111 replicable replicated |
|
|
17 Top |
CAMK1 (trans) Calcium/calmodulin-dependent protein kinase type 1 |
F5ae, SELPb, SELLb |
rs4525 1:169,511,734 |
2×10-110 replicable replicated |
|
|
18 Top |
BST1 (cis) ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 |
FAM200Babce, FBXL5abc, BST1abe, CC2D2Aa, FGFBP2b [2 more]C1QTNF7b, CD38c |
rs2302465 4:15,709,192 |
1.4×10-108 replicable replicated |
|
|
19 Top |
IL-18 Ra (cis) Interleukin-18 receptor 1 |
IL18R1abc, IL1RL1abc, IL18RAPabc, SLC9A4abc, IL1R2b [4 more]SLC9A2b, RP11-400G3.5d, CYP2C19d, ZNF32d |
rs2058622 2:102,985,424 |
9×10-108 replicable replicated |
|
|
20 Top |
Chitotriosidase-1 (cis) |
CHIT1ac, ADORA1c |
rs12141375 1:203,181,362 |
9.3×10-108 replicable replicated |
|
efficacy |
21 Top |
PCSK7 (cis) Proprotein convertase subtilisin/kexin type 7 |
TAGLNabc, PCSK7abc, PAFAH1B2ac, SIDT2ac, SIK3b [1 more]CBLN2d |
rs9326248 11:116,999,225 |
1.7×10-105 replicable replicated |
|
unspecified application |
22 Top |
SAA (cis) Serum amyloid A-1 protein |
SAA1abc, TSG101b, PTPN5b, HPS5b, SAA2c [2 more]SAA2-SAA4c, GTF2H1c |
rs1993373 11:18,280,635 |
2.2×10-105 replicable replicated |
|
diagnosis, unspecified application |
23 Top |
ADAMTS-5 (cis) A disintegrin and metalloproteinase with thrombospondin motifs 5 |
ADAMTS5ae |
rs2830585 21:28,305,212 |
3.9×10-104 replicable replicated |
|
|
24 Top |
ECM1 (cis) Extracellular matrix protein 1 |
ECM1ace, MRPS21ac, RPRD2ac, TARS2ac, AC242988.1a [8 more]PRPF3a, VPS45b, APH1Ab, MCL1b, ANXA9b, CDC42SE1c, ADAMTSL4c, ENSAc |
rs13294 1:150,484,987 |
7.7×10-102 replicable replicated |
|
diagnosis |
25 Top |
GCP-2 (cis) C-X-C motif chemokine 6 |
CXCL6ac, PF4V1c |
rs16850073 4:74,703,999 |
9.7×10-98 replicable replicated |
|
unspecified application |
26 Top |
Kininogen, HMW (cis) Kininogen-1 |
KNG1ae |
rs2304456 3:186,445,052 |
2.9×10-97 replicable replicated |
|
|
26 |
LCMT1 (trans) Leucine carboxyl methyltransferase 1 |
KNG1ae |
rs2304456 3:186,445,052 |
1.4×10-10 replicated |
|
|
27 Top |
TIMP-3 (cis) Metalloproteinase inhibitor 3 |
SYN3a |
rs2097326 22:33,165,020 |
4.4×10-97 replicable replicated |
|
diagnosis, prognosis, unspecified application |
28 Top |
sE-Selectin (trans) E-Selectin |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
1.2×10-96 replicable replicated |
|
diagnosis, disease progression, efficacy, unspecified application |
28 |
IR (trans) Insulin receptor |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
3.9×10-44 replicable replicated |
insulin detemir, INS, canakinumab/INS, insulin aspart/insulin detemir, ceritinib, insulin glargine/insulin lispro, insulin aspart, insulin glulisine, insulin lispro, insulin glargine, protamine zinc insulin |
prognosis |
28 |
VEGF sR3 (trans) Vascular endothelial growth factor receptor 3 |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
1.1×10-31 replicable replicated |
sunitinib, pazopanib, axitinib, CEP 7055, tivozanib, motesanib, telatinib, cabozantinib, nintedanib, regorafenib, bortezomib/sorafenib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, cabozantinib/erlotinib, sorafenib, vandetanib |
diagnosis, disease progression, efficacy, prognosis |
28 |
CD36 ANTIGEN (trans) Platelet glycoprotein 4 |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
1.3×10-29 replicable |
|
efficacy |
28 |
Endoglin (cis) |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
6×10-26 replicable |
|
disease progression, efficacy |
28 |
Met (trans) Hepatocyte growth factor receptor |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
3.3×10-19 replicable replicated |
crizotinib, tivantinib, cabozantinib, INC280, cabozantinib/erlotinib |
diagnosis, disease progression, efficacy, prognosis, response to therapy, unspecified application |
28 |
sICAM-2 (trans) Intercellular adhesion molecule 2 |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
7.5×10-15 |
|
|
28 |
VEGF sR2 (trans) Vascular endothelial growth factor receptor 2 |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
3.1×10-13 replicated |
AEE 788, sunitinib, cediranib, pazopanib, axitinib, XL647, CEP 7055, brivanib alaninate, CHIR-265, tivozanib, motesanib, OSI-930, telatinib, ramucirumab, cabozantinib, nintedanib, regorafenib, bortezomib/sorafenib, lapatinib/pazopanib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, cabozantinib/erlotinib, docetaxel/ramucirumab, vatalanib, sorafenib, vandetanib, pegaptanib |
disease progression, efficacy, prognosis, response to therapy, safety |
28 |
ST4S6 (trans) Carbohydrate sulfotransferase 15 |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
6.7×10-13 |
|
|
28 |
P-Selectin (trans) |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
7.4×10-13 replicated |
|
efficacy, safety, unspecified application |
28 |
TLR4:MD-2 complex (trans) Toll-like receptor 4:Lymphocyte antigen 96 complex |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
3.4×10-12 |
|
|
28 |
Cadherin-5 (trans) |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
4.8×10-12 |
|
diagnosis |
28 |
JAG1 (trans) Protein jagged-1 |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
4.7×10-11 |
|
efficacy |
28 |
OX2G (trans) OX-2 membrane glycoprotein |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
8×10-11 replicated |
|
|
28 |
CD109 (trans) CD109 antigen |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [3 more]SURF1c, SURF6c, GBGT1c |
rs651007 9:136,153,875 |
8.4×10-9 |
|
|
29 Top |
C1-Esterase Inhibitor (cis) Plasma protease C1 inhibitor |
SERPING1abe, YPEL4bc, ZDHHC5bc, RP11-872D17.8b, PRG2b [7 more]CLP1b, RTN4RL2b, SLC43A3b, SLC43A1b, SSRP1b, TIMM10c, MED19c |
rs11603020 11:57,374,332 |
5×10-96 replicable replicated |
|
|
30 Top |
HCC-4 (cis) C-C motif chemokine 16 |
CCL16a, CCL14a, CCL15-CCL14a |
rs33995560 17:34,303,771 |
1.9×10-95 replicable replicated |
|
|
31 Top |
HRG (cis) Histidine-rich glycoprotein |
HRGae |
rs2228243 3:186,395,113 |
4.7×10-94 replicable replicated |
|
|
31 |
MP2K4 (trans) Dual specificity mitogen-activated protein kinase kinase 4 |
HRGae |
rs2228243 3:186,395,113 |
4.2×10-82 replicable replicated |
|
|
31 |
CD27 (trans) CD27 antigen |
HRGae |
rs2228243 3:186,395,113 |
1.7×10-45 replicable |
|
unspecified application |
31 |
Semaphorin 3A (trans) Semaphorin-3A |
HRGae |
rs2228243 3:186,395,113 |
3.3×10-10 |
|
|
32 Top |
IL-17 sR (cis) Interleukin-17 receptor A |
IL17RAac, CECR6a |
rs3827278 22:17,595,915 |
2×10-93 replicable replicated |
|
|
33 Top |
MIP-5 (cis) C-C motif chemokine 15 |
CCL15ab, CCL15-CCL14a, CCL23a, CCL16b, CCL14b |
rs7221769 17:34,334,448 |
3.6×10-93 replicable replicated |
|
|
33 |
HCC-1 (cis) C-C motif chemokine 14 |
CCL15ab, CCL15-CCL14a, CCL23a, CCL16b, CCL14b |
rs7221769 17:34,334,448 |
6×10-13 |
|
|
34 Top |
MBL (cis) Mannose-binding protein C |
MBL2abc, DKK1b |
rs10824796 10:54,534,613 |
1×10-89 replicable replicated |
|
diagnosis |
35 Top |
SPINT2 (cis) Kunitz-type protease inhibitor 2 |
YIF1Bac, C19orf33ac, CATSPERGac, CTB-102L5.4a, KCNK6a [3 more]PSMD8b, PPP1R14Ac, SPINT2c |
rs8112211 19:38,824,581 |
1×10-88 replicable replicated |
|
diagnosis |
36 Top |
DC-SIGN (trans) CD209 antigen |
ABOabc, TSC1b, AK8b, SARDHb, GBGT1c |
rs505922 9:136,149,229 |
7.6×10-86 replicable replicated |
|
|
36 |
vWF (trans) von Willebrand factor |
ABOabc, TSC1b, AK8b, SARDHb, GBGT1c |
rs612169 9:136,143,442 |
1.2×10-20 replicable replicated |
|
diagnosis, efficacy, prognosis |
36 |
MBL (trans) Mannose-binding protein C |
ABOabc, TSC1b, AK8b, SARDHb, GBGT1c |
rs687289 9:136,137,106 |
8.2×10-10 |
|
diagnosis |
37 Top |
GPC5 (cis) Glypican-5 |
GPC5a |
rs342706 13:92,417,058 |
1.2×10-83 replicable replicated |
|
|
38 Top |
TAFI (cis) Carboxypeptidase B2 |
CPB2ace, ZC3H13ac, LRRC63b, LCP1b |
rs3742264 13:46,648,094 |
2.8×10-83 replicable replicated |
|
|
39 Top |
SIG14 (cis) Sialic acid-binding Ig-like lectin 14 |
SIGLEC14ac, SIGLEC5ac, SIGLEC5a |
rs7250849 19:52,158,316 |
4.3×10-82 replicable replicated |
|
|
40 Top |
KYNU (cis) Kynureninase |
KYNUae |
rs9013 2:143,798,189 |
1×10-81 replicable replicated |
|
|
41 Top |
ILT-2 (cis) Leukocyte immunoglobulin-like receptor subfamily B member 1 |
LILRA1abc, LILRB1abe, LILRB4ab, LILRA2bc, LILRB2bc [14 more]KIR3DL2b, KIR3DL1b, KIR2DL3b, LILRA6b, KIR2DL1b, LAIR1b, LENG8b, LILRA5b, KIR2DL4b, FCARb, NLRP2b, KIR3DL3b, KIR3DX1b, LILRB5c |
rs2004318 19:55,138,232 |
1.8×10-80 replicable replicated |
|
|
42 Top |
EphA1 (cis) Ephrin type-A receptor 1 |
EPHA1ace, ZYXac |
rs4725617 7:143,097,100 |
2.9×10-80 replicable |
|
|
43 Top |
MP2K4 (trans) Dual specificity mitogen-activated protein kinase kinase 4 |
HRGae |
rs1042445 3:186,395,436 |
8.4×10-78 replicable replicated |
|
|
43 |
CD27 (trans) CD27 antigen |
HRGae |
rs1042445 3:186,395,436 |
1.6×10-28 replicable |
|
unspecified application |
43 |
ER (trans) Estrogen receptor |
HRGae |
rs1042445 3:186,395,436 |
6.2×10-18 |
17-alpha-ethinylestradiol, fulvestrant, beta-estradiol, estradiol 17beta-cypionate, estriol, estrone, estradiol valerate, mestranol, CHF-4227, bazedoxifene, estradiol valerate/testosterone enanthate, TAS-108, ethinyl estradiol/ethynodiol diacetate, estradiol acetate, esterified estrogens, estradiol cypionate/medroxyprogesterone acetate, estradiol/norethindrone acetate, synthetic conjugated estrogens, A, estradiol cypionate/testosterone cypionate, B, etonogestrel, CC8490, MITO-4509, cyproterone acetate/ethinyl estradiol, ethinyl estradiol/etonogestrel, chlorotrianisene, megestrol acetate/tamoxifen, sulindac/tamoxifen, sulindac/toremifene, raloxifene/sulindac, ethynodiol, goserelin/tamoxifen, raloxifene/teriparatide, desogestrel/ethinyl estradiol, drospirenone/ethinyl estradiol, premarin, ethinyl estradiol/norelgestromin, ethinyl estradiol/norethindrone, ethinyl estradiol/levonorgestrel, ethinyl estradiol/norgestrel, ethinyl estradiol/norgestimate, conjugated estrogen/medroxyprogesterone acetate, diethylstilbestrol, ospemifene, toremifene, tamoxifen, raloxifene, arzoxifene, clomiphene, estramustine phosphate, diethylstilbestrol diphosphate, estropipate, dienestrol, estramustine, medroxyprogesterone acetate, desogestrel, danazol, trilostane, fluoxymesterone, norgestimate, progesterone |
diagnosis, disease progression, efficacy, prognosis, response to therapy |
44 Top |
IL-1 R4 (cis) Interleukin-1 receptor-like 1 |
IL1RL1abc, IL18R1abc, MAP4K4b, IL1R1b, IL1R2b [2 more]SLC9A4c, IL18RAPc |
rs12712135 2:102,930,948 |
4.4×10-76 replicable replicated |
|
|
45 Top |
Granulysin (cis) |
VAMP8bc, CAPGb, IMMTb, TMEM150Ab, TGOLN2b [12 more]USP39b, MRPL35b, POLR1Ab, SFTPBb, SH2D6b, MAT2Ab, VAMP5b, PTCD3b, ATOH8c, GGCXc, GNLYc, MLH3d |
rs12151621 2:85,934,499 |
5.8×10-76 replicable replicated |
|
|
46 Top |
Haptoglobin, Mixed Type (cis) Haptoglobin |
TXNL4Ba, HPRa, MARVELD3c |
rs217181 16:72,114,002 |
1.3×10-75 |
|
diagnosis, efficacy, unspecified application |
46 |
Ferritin (trans) |
TXNL4Ba, HPRa, MARVELD3c |
rs217181 16:72,114,002 |
4.1×10-16 |
|
|
46 |
Heparin cofactor II (trans) Heparin cofactor 2 |
TXNL4Ba, HPRa, MARVELD3c |
rs217181 16:72,114,002 |
3×10-12 |
ardeparin, glucuronyl glucosamine glycan sulfate |
disease progression |
47 Top |
Tenascin (cis) |
TNCae |
rs45602433 9:117,835,899 |
3.9×10-74 replicable |
|
diagnosis, response to therapy |
48 Top |
ILT-4 (cis) Leukocyte immunoglobulin-like receptor subfamily B member 2 |
LILRA1bc, LILRB2bc, LILRB3b, LAIR1b, KIR2DL3b [13 more]LENG8b, LILRA5b, LILRB4b, OSCARb, NLRP12b, MYADMb, LILRA6b, LILRA2b, LILRB1b, KIR3DL3b, KIR2DL1b, TSEN34c, ITIH6d |
rs103294 19:54,797,848 |
1.7×10-73 replicable replicated |
|
|
49 Top |
Siglec-9 (cis) Sialic acid-binding Ig-like lectin 9 |
CTU1ac |
rs2691273 19:51,596,136 |
3.1×10-73 replicable replicated |
|
|
50 Top |
CPNE1 (cis) Copine-1 |
CPNE1abce, RBM39abc, SCAND1abc, PHF20abe, SPAG4ab [9 more]RBM12ab, NFS1ab, ROMO1ab, CEP250bc, ERGIC3bc, EPB41L1bc, RP1-309K20.6a, CNBD2a, GDF5b |
rs2425143 20:34,350,666 |
3.6×10-73 replicable replicated |
|
|
51 Top |
Fucosyltransferase 3 (cis) Galactoside 3(4)-L-fucosyltransferase |
FUT3ae, FUT6a |
rs778986 19:5,844,537 |
8.8×10-73 replicable replicated |
|
|
52 Top |
VEGF sR3 (trans) Vascular endothelial growth factor receptor 3 |
DCBLD2c, CPOXc, ST3GAL6c |
rs10935480 3:98,431,986 |
9.9×10-70 replicable replicated |
sunitinib, pazopanib, axitinib, CEP 7055, tivozanib, motesanib, telatinib, cabozantinib, nintedanib, regorafenib, bortezomib/sorafenib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, cabozantinib/erlotinib, sorafenib, vandetanib |
diagnosis, disease progression, efficacy, prognosis |
53 Top |
MCP-3 (cis) C-C motif chemokine 7 |
CCL8ae |
rs3138036 17:32,647,544 |
1.8×10-69 replicable replicated |
|
|
53 |
MCP-2 (cis) C-C motif chemokine 8 |
CCL8ae |
rs3138036 17:32,647,544 |
1.3×10-14 |
|
unspecified application |
54 Top |
G-CSF (trans) Granulocyte colony-stimulating factor |
APOC4ae, APOC4-APOC2ae, APOC2a, CEACAM19b, BCL3b [3 more]APOEc, CLPTM1c, APOC1c |
rs5167 19:45,448,465 |
2.1×10-69 replicable replicated |
filgrastim |
diagnosis |
55 Top |
IL-12 Rb1 (cis) Interleukin-12 receptor subunit beta-1 |
IL12RB1ace |
rs376008 19:18,189,568 |
6.3×10-69 replicable replicated |
|
|
56 Top |
annexin II (cis) Annexin A2 |
ICE2ac, ANXA2a, RORAa |
rs36032232 15:60,776,991 |
6.9×10-66 replicable replicated |
|
diagnosis, unspecified application |
57 Top |
Semaphorin 3E (cis) Semaphorin-3E |
SEMA3Eabe, CHI3L2d |
rs17284969 7:83,006,262 |
2.4×10-65 replicable replicated |
|
|
58 Top |
Coagulation Factor VII (cis) |
F10ac, F7c |
rs776905 13:113,781,942 |
9.2×10-65 replicable replicated |
nematode anticoagulant protein c2 |
unspecified application |
59 Top |
RAP (trans) alpha-2-macroglobulin receptor-associated protein |
HLA-Babe, HLA-Cab, MICBab, GTF2H4b, HSPA1Lb [11 more]DDX39Bb, LTAb, LY6G5Bb, ATP6V1G2b, VARSb, MICAb, NCR3b, HCG27b, TNFb, PRRC2Ab, GPANK1b |
rs1622406 6:31,308,862 |
7.1×10-63 |
|
|
60 Top |
Lysozyme (cis) Lysozyme C |
LYZac, YEATS4c, CPMc |
rs7959452 12:69,735,492 |
1.2×10-60 replicable replicated |
|
unspecified application |
61 Top |
ENTP5 (cis) Ectonucleoside triphosphate diphosphohydrolase 5 |
ENTPD5ac, CCDC176ac, ALDH6A1ac, LIN52ac, RP5-1021I20.4a [7 more]PTGR2a, ZNF410a, FAM161Ba, COQ6a, AC005480.1a, ABCD4b, PNMA1b |
rs17094448 14:74,440,119 |
1.2×10-60 replicable replicated |
|
|
62 Top |
BST1 (cis) ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 |
CD38c, BST1c |
rs12651314 4:15,753,570 |
3.7×10-58 replicable replicated |
|
|
63 Top |
SLAF7 (cis) SLAM family member 7 |
SLAMF7ac, LY9bc, SLAMF1b, B4GALT3b, NCSTNb [1 more]PVRL4b |
rs489286 1:160,722,550 |
1.5×10-57 replicable replicated |
|
|
64 Top |
FCRL3 (cis) Fc receptor-like protein 3 |
FCRL3ace, ATP1A4c, FCRL1c |
rs7522061 1:157,668,390 |
5.4×10-57 replicable replicated |
|
|
65 Top |
IL-17E (trans) Interleukin-25 |
OAFabe, POU2F3bc, ARHGEF12b, TMEM136b, TRIM29b [1 more]PVRL1b |
rs692804 11:120,099,368 |
1.1×10-56 replicable replicated |
|
|
66 Top |
TXD12 (trans) Thioredoxin domain-containing protein 12 |
CCDC36a, USP4a, MST1c, ZNF589c, APEHc [2 more]NICN1c, AMTc |
rs35395347 3:49,334,797 |
7.8×10-55 |
|
|
67 Top |
Haptoglobin, Mixed Type (cis) Haptoglobin |
DHX38ac, TXNL4Ba, PMFBP1a, HPRc, DHODHc [1 more]HPc |
rs9302635 16:72,144,174 |
6.3×10-54 replicable replicated |
|
diagnosis, efficacy, unspecified application |
67 |
Ferritin (trans) |
DHX38ac, TXNL4Ba, PMFBP1a, HPRc, DHODHc [1 more]HPc |
rs9302635 16:72,144,174 |
2.8×10-10 replicated |
|
|
68 Top |
SPARCL1 (cis) SPARC-like protein 1 |
SPARCL1abce, NUDT9c, HSD17B11c, HSD17B13c, PPM1Kc |
rs4693167 4:88,423,913 |
2.6×10-53 replicable replicated |
|
disease progression |
69 Top |
Cadherin-5 (trans) |
ABOabce, OBP2Bbc, DBHb, SURF2b, ADAMTSL2b [12 more]GFI1Bb, SURF1b, ADAMTS13b, SARDHb, RALGDSb, SURF4b, C9orf9b, REXO4b, AK8b, GTF3C5b, MED22c, SLC2A6c |
rs8176749 9:136,131,188 |
6.1×10-53 replicable replicated |
|
diagnosis |
69 |
sTie-1 (trans) Tyrosine-protein kinase receptor Tie-1, soluble |
ABOabce, OBP2Bbc, DBHb, SURF2b, ADAMTSL2b [12 more]GFI1Bb, SURF1b, ADAMTS13b, SARDHb, RALGDSb, SURF4b, C9orf9b, REXO4b, AK8b, GTF3C5b, MED22c, SLC2A6c |
rs8176749 9:136,131,188 |
1.7×10-51 replicable replicated |
|
|
69 |
sTie-2 (trans) Angiopoietin-1 receptor, soluble |
ABOabce, OBP2Bbc, DBHb, SURF2b, ADAMTSL2b [12 more]GFI1Bb, SURF1b, ADAMTS13b, SARDHb, RALGDSb, SURF4b, C9orf9b, REXO4b, AK8b, GTF3C5b, MED22c, SLC2A6c |
rs8176749 9:136,131,188 |
1.1×10-35 replicable replicated |
cabozantinib, regorafenib, ponatinib, cabozantinib/erlotinib, vandetanib |
efficacy |
69 |
Endoglin (cis) |
ABOabce, OBP2Bbc, DBHb, SURF2b, ADAMTSL2b [12 more]GFI1Bb, SURF1b, ADAMTS13b, SARDHb, RALGDSb, SURF4b, C9orf9b, REXO4b, AK8b, GTF3C5b, MED22c, SLC2A6c |
rs8176749 9:136,131,188 |
5.6×10-17 |
|
disease progression, efficacy |
69 |
BCAM (trans) Basal Cell Adhesion Molecule |
ABOabce, OBP2Bbc, DBHb, SURF2b, ADAMTSL2b [12 more]GFI1Bb, SURF1b, ADAMTS13b, SARDHb, RALGDSb, SURF4b, C9orf9b, REXO4b, AK8b, GTF3C5b, MED22c, SLC2A6c |
rs8176749 9:136,131,188 |
1.5×10-11 replicated |
|
diagnosis |
69 |
CD109 (trans) CD109 antigen |
ABOabce, OBP2Bbc, DBHb, SURF2b, ADAMTSL2b [12 more]GFI1Bb, SURF1b, ADAMTS13b, SARDHb, RALGDSb, SURF4b, C9orf9b, REXO4b, AK8b, GTF3C5b, MED22c, SLC2A6c |
rs8176749 9:136,131,188 |
1.7×10-11 |
|
|
69 |
VEGF sR3 (trans) Vascular endothelial growth factor receptor 3 |
ABOabce, OBP2Bbc, DBHb, SURF2b, ADAMTSL2b [12 more]GFI1Bb, SURF1b, ADAMTS13b, SARDHb, RALGDSb, SURF4b, C9orf9b, REXO4b, AK8b, GTF3C5b, MED22c, SLC2A6c |
rs8176749 9:136,131,188 |
7.9×10-11 |
sunitinib, pazopanib, axitinib, CEP 7055, tivozanib, motesanib, telatinib, cabozantinib, nintedanib, regorafenib, bortezomib/sorafenib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, cabozantinib/erlotinib, sorafenib, vandetanib |
diagnosis, disease progression, efficacy, prognosis |
69 |
TCCR (trans) Interleukin-27 receptor subunit alpha |
ABOabce, OBP2Bbc, DBHb, SURF2b, ADAMTSL2b [12 more]GFI1Bb, SURF1b, ADAMTS13b, SARDHb, RALGDSb, SURF4b, C9orf9b, REXO4b, AK8b, GTF3C5b, MED22c, SLC2A6c |
rs8176749 9:136,131,188 |
8.3×10-11 |
|
|
69 |
Notch 1 (cis) Neurogenic locus notch homolog protein 1 |
ABOabce, OBP2Bbc, DBHb, SURF2b, ADAMTSL2b [12 more]GFI1Bb, SURF1b, ADAMTS13b, SARDHb, RALGDSb, SURF4b, C9orf9b, REXO4b, AK8b, GTF3C5b, MED22c, SLC2A6c |
rs8176749 9:136,131,188 |
6×10-10 replicated |
|
diagnosis, efficacy |
70 Top |
CYTF (cis) Cystatin-F |
CST7ac, APMAPac, NINLc |
rs6138458 20:24,973,769 |
7.6×10-53 replicable replicated |
|
|
71 Top |
GRN (trans) Granulins |
PSRC1ac, CELSR2ac, AMPD2b, SORT1c |
rs646776 1:109,818,530 |
1×10-52 replicable replicated |
|
|
71 |
Catalase (trans) |
PSRC1ac, CELSR2ac, AMPD2b, SORT1c |
rs646776 1:109,818,530 |
1.5×10-11 |
fomepizole |
diagnosis |
71 |
RGMA (trans) Repulsive guidance molecule A |
PSRC1ac, CELSR2ac, AMPD2b, SORT1c |
rs646776 1:109,818,530 |
5.1×10-10 |
|
|
72 Top |
Hemopexin (trans) |
CFHR4ae, CFHR2a, ASPMa, ZBTB41a |
rs10494745 1:196,887,457 |
1.8×10-52 replicable replicated |
|
|
73 Top |
Esterase D (cis) S-formylglutathione hydrolase |
ESDa |
rs947409 13:47,377,928 |
2.2×10-52 replicable replicated |
|
|
74 Top |
TLR4:MD-2 complex (cis) Toll-like receptor 4:Lymphocyte antigen 96 complex |
TLR4ace, BRINP1c |
rs4986791 9:120,475,602 |
1.8×10-50 replicable replicated |
|
|
75 Top |
kallikrein 12 (cis) Kallikrein-12 |
KLK12ac |
rs8103941 19:51,546,852 |
5.3×10-50 replicable replicated |
|
|
76 Top |
Hemopexin (trans) |
CFHR4ac, CFHR2a, CFHR2a, CFHR5a, CFHR1c [2 more]CFHR3c, CFHc |
rs10801582 1:196,944,357 |
1.1×10-49 replicable replicated |
|
|
77 Top |
Fibronectin (cis) |
FN1abce |
rs1250258 2:216,300,185 |
1.3×10-49 replicable replicated |
ocriplasmin |
diagnosis, efficacy, prognosis, unspecified application |
77 |
FN1.3 (cis) Fibronectin Fragment 3 |
FN1abce |
rs1250258 2:216,300,185 |
1.8×10-42 replicable replicated |
ocriplasmin |
diagnosis, efficacy, prognosis, unspecified application |
77 |
FN1.4 (cis) Fibronectin Fragment 4 |
FN1abce |
rs1250258 2:216,300,185 |
1.2×10-9 replicated |
ocriplasmin |
diagnosis, efficacy, prognosis, unspecified application |
78 Top |
KI2L4 (cis) Killer cell immunoglobulin-like receptor 2DL4 |
sentinel not in SNiPA's database
|
rs618835 19:55,316,329 |
2.3×10-49 |
|
|
79 Top |
CAMK1 (trans) Calcium/calmodulin-dependent protein kinase type 1 |
CPN1a, HIF1ANc |
rs7091871 10:101,810,304 |
1×10-48 replicable replicated |
|
|
79 |
Calpastatin (trans) |
CPN1a, HIF1ANc |
rs7091871 10:101,810,304 |
1.4×10-12 replicated |
|
|
80 Top |
IGF-II receptor (cis) Cation-independent mannose-6-phosphate receptor |
IGF2Ra |
rs600324 6:160,519,276 |
7.1×10-48 replicable replicated |
|
|
81 Top |
Kallistatin (cis) |
SERPINA5ac, SERPINA4a, SERPINA3c, SERPINA3c |
rs882732 14:95,027,722 |
7.7×10-48 replicable replicated |
|
|
82 Top |
Semaphorin 3A (trans) Semaphorin-3A |
SARM1ac, VTNa, SLC46A1a, TMEM199c, POLDIP2c [1 more]TMEM97c |
rs2239908 17:26,725,265 |
9.5×10-48 replicable replicated |
|
|
82 |
CAMK1D (trans) Calcium/calmodulin-dependent protein kinase type 1D |
SARM1ac, VTNa, SLC46A1a, TMEM199c, POLDIP2c [1 more]TMEM97c |
rs2239908 17:26,725,265 |
3×10-24 replicable replicated |
|
|
82 |
IL-5 (trans) Interleukin-5 |
SARM1ac, VTNa, SLC46A1a, TMEM199c, POLDIP2c [1 more]TMEM97c |
rs2239908 17:26,725,265 |
4.8×10-24 replicable |
|
diagnosis, efficacy, response to therapy |
82 |
WISP-1 (trans) WNT1-inducible-signaling pathway protein 1 |
SARM1ac, VTNa, SLC46A1a, TMEM199c, POLDIP2c [1 more]TMEM97c |
rs2239908 17:26,725,265 |
1.1×10-10 replicated |
|
|
82 |
Cytidylate kinase (trans) UMP-CMP kinase |
SARM1ac, VTNa, SLC46A1a, TMEM199c, POLDIP2c [1 more]TMEM97c |
rs2239908 17:26,725,265 |
8×10-10 |
|
|
82 |
Marapsin (trans) Serine protease 27 |
SARM1ac, VTNa, SLC46A1a, TMEM199c, POLDIP2c [1 more]TMEM97c |
rs2239908 17:26,725,265 |
1.6×10-9 |
|
|
83 Top |
ASAHL (cis) N-acylethanolamine-hydrolyzing acid amidase |
NAAAabce, CXCL9ac, ART3ac, CXCL11ac, SDAD1a [7 more]AC110615.1a, AC112719.2a, CCDC158b, NUP54b, USO1b, CXCL10c, SCARB2c |
rs4859571 4:76,857,309 |
1.1×10-46 replicable replicated |
|
|
84 Top |
Siglec-6 (cis) Sialic acid-binding Ig-like lectin 6 |
SIGLEC6abce, SIGLEC12c, ZNF175c, SIGLEC5c, SIGLEC5c |
rs2124910 19:52,025,247 |
2.7×10-46 replicable replicated |
|
|
85 Top |
CD109 (cis) CD109 antigen |
CD109ac, EEF1A1b |
rs10455097 6:74,493,432 |
3.2×10-46 replicable replicated |
|
|
86 Top |
Haptoglobin, Mixed Type (cis) Haptoglobin |
HPac, HPRac, DHX38ac, TXNL4Ba, PMFBP1a [1 more]DHODHc |
rs2000999 16:72,108,093 |
7.4×10-45 |
|
diagnosis, efficacy, unspecified application |
86 |
Heparin cofactor II (trans) Heparin cofactor 2 |
HPac, HPRac, DHX38ac, TXNL4Ba, PMFBP1a [1 more]DHODHc |
rs2000999 16:72,108,093 |
8.3×10-17 |
ardeparin, glucuronyl glucosamine glycan sulfate |
disease progression |
86 |
Hemoglobin (trans) |
HPac, HPRac, DHX38ac, TXNL4Ba, PMFBP1a [1 more]DHODHc |
rs2000999 16:72,108,093 |
5.3×10-12 |
|
|
87 Top |
PARC (cis) C-C motif chemokine 18 |
sentinel not in SNiPA's database
|
rs9904601 17:34,372,006 |
2.5×10-43 replicable replicated |
|
efficacy, safety |
87 |
MIP-1a (cis) C-C motif chemokine 3 |
sentinel not in SNiPA's database
|
rs9904601 17:34,372,006 |
1.2×10-17 replicable replicated |
|
diagnosis, efficacy, prognosis |
88 Top |
HCC-1 (cis) C-C motif chemokine 14 |
CCL14ab, CCL16a, CCL15-CCL14a, CCL15a |
rs41341749 17:34,310,702 |
3×10-43 replicable replicated |
|
|
88 |
MPIF-1 (cis) C-C motif chemokine 23 |
CCL14ab, CCL16a, CCL15-CCL14a, CCL15a |
rs41341749 17:34,310,702 |
3.1×10-32 replicable replicated |
|
|
88 |
PARC (cis) C-C motif chemokine 18 |
CCL14ab, CCL16a, CCL15-CCL14a, CCL15a |
rs41341749 17:34,310,702 |
6.3×10-19 |
|
efficacy, safety |
88 |
MIP-1a (cis) C-C motif chemokine 3 |
CCL14ab, CCL16a, CCL15-CCL14a, CCL15a |
rs41341749 17:34,310,702 |
1×10-9 |
|
diagnosis, efficacy, prognosis |
89 Top |
IL-17 RD (cis) Interleukin-17 receptor D |
IL17RDae, FLNBc, ARHGEF3c |
rs1463657 3:57,137,461 |
1.4×10-42 replicable replicated |
|
|
90 Top |
CYTD (cis) Cystatin-D |
CST5ac, CST2a, CSTL1b, CST8b, CST11b [1 more]GGTLC1b |
rs6138152 20:23,850,130 |
1.8×10-42 replicable replicated |
|
|
91 Top |
TXD12 (trans) Thioredoxin domain-containing protein 12 |
RBM6ac, RNF123ae, BSNa, AMIGO3a, GMPPBa [18 more]IP6K1a, TRAIPa, CAMKVa, RBM5a, NCKIPSDc, AMTc, WDR6c, TMEM89c, SEMA3Fc, NICN1c, CCDC36c, SLC26A6c, C3orf62c, USP4c, APEHc, UBA7c, HYAL3c, CCDC71c |
rs4688759 3:50,008,118 |
1.8×10-42 replicable replicated |
|
|
92 Top |
HCC-1 (cis) C-C motif chemokine 14 |
CCL14ae, CCL16a, CCL15-CCL14a, CCL15a |
rs16971802 17:34,311,387 |
9.6×10-41 replicable replicated |
|
|
93 Top |
Collectin Kidney 1 (cis) Collectin-11 |
COLEC11ac, ALLCc |
rs7588285 2:3,648,186 |
1.1×10-40 replicable replicated |
|
|
93 |
IL-19 (trans) Interleukin-19 |
COLEC11ac, ALLCc |
rs7588285 2:3,648,186 |
2.7×10-37 replicable replicated |
|
|
93 |
IL-1b (trans) Interleukin-1 beta |
COLEC11ac, ALLCc |
rs7588285 2:3,648,186 |
2.5×10-9 |
canakinumab, gevokizumab, canakinumab/INS, gallium nitrate |
diagnosis, efficacy, prognosis |
94 Top |
WFKN2 (cis) WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 |
TOB1abc, WFIKKN2ab, SPATA20b, CACNA1Gb, NME2b [7 more]MYCBPAPb, ANKRD40b, ACSF2b, XYLT2b, RSAD1b, ABCC3b, LUC7L3b |
rs3803884 17:48,919,039 |
1.4×10-40 replicable replicated |
|
|
95 Top |
TXD12 (trans) Thioredoxin domain-containing protein 12 |
IP6K2abce, CELSR3abc, NCKIPSDabc, ARIH2abc, WDR6abc [29 more]KLHDC8Babc, CCDC36abc, USP19abe, PRKAR2Aab, P4HTMab, DALRD3ab, IMPDH2ab, QARSab, CCDC71ac, SLC26A6bc, AMTbc, QRICH1ae, SLC25A20a, ARIH2OSa, NDUFAF3a, LAMB2a, C3orf84a, ATRIPb, SPINK8b, UCN2b, COL7A1b, TMEM89c, NICN1c, C3orf62c, USP4c, RBM6c, UBA7c, TMA7c, SEMA3Fc |
rs11715835 3:48,770,732 |
2.2×10-40 replicable replicated |
|
|
96 Top |
Coagulation Factor XI (trans) |
KNG1ae |
rs5030062 3:186,454,180 |
3×10-40 replicable replicated |
|
|
96 |
Prekallikrein (trans) Plasma kallikrein |
KNG1ae |
rs5030062 3:186,454,180 |
1.8×10-35 replicable replicated |
aprotinin, ecallantide |
|
97 Top |
Cathepsin S (cis) |
CTSSace, GOLPH3La, HORMAD1a, CA14b, CTSKb [1 more]SEMA6Cc |
rs41271951 1:150,737,220 |
4.1×10-40 |
|
|
98 Top |
C1s (trans) Complement C1s subcomponent |
CFHa, CFHR3c |
rs6695321 1:196,675,861 |
9.4×10-40 replicable replicated |
SERPING1 |
|
98 |
complement factor H-related 5 (cis) Complement factor H-related protein 5 |
CFHa, CFHR3c |
rs6695321 1:196,675,861 |
2.7×10-20 replicable |
|
|
99 Top |
Gro-a (cis) Growth-regulated alpha protein |
CXCL1a, ALBb, AFPb, PF4c, CXCL6c |
rs16845091 4:74,758,801 |
1.6×10-39 replicable replicated |
|
disease progression |
100 Top |
a2-HS-Glycoprotein (cis) Alpha-2-HS-glycoprotein |
AHSGa |
rs2518136 3:186,337,827 |
1.7×10-39 replicable replicated |
|
unspecified application |
101 Top |
TIMD3 (cis) Hepatitis A virus cellular receptor 2 |
HAVCR2abce, ADAM19b, HAVCR1c, MED7c |
rs4704846 5:156,513,344 |
1.8×10-39 replicable replicated |
|
unspecified application |
102 Top |
CNTN2 (cis) Contactin-2 |
CNTN2abc, RBBP5abc, DSTYKabc, TMEM81ace, TMCC2a |
rs4951168 1:205,053,219 |
2.1×10-39 replicable replicated |
|
|
103 Top |
bFGF (cis) Fibroblast growth factor 2 |
FGF2ac |
rs308403 4:123,757,748 |
5.8×10-39 replicable replicated |
pentosan polysulfate, suradista, sucralfate |
diagnosis, efficacy, prognosis |
104 Top |
Angiogenin (cis) |
RNASE4abc, ANGabc, RP11-903H12.5ac |
rs17114671 14:21,155,270 |
1.9×10-38 replicable replicated |
|
response to therapy |
105 Top |
MICB (cis) MHC class I polypeptide-related sequence B |
HLA-Babc, MICBabc, DDX39Babc, HLA-Cac, MICAac [58 more]LTBab, LTAab, LST1ac, NCR3ab, VARS2bc, PSORS1C2bc, CCHCR1bc, STK19bc, HCG27a, ATP6V1G2-DDX39Ba, ATP6V1G2a, NFKBIL1a, TNFa, POU5F1b, LY6G6Db, DDR1b, LY6G6Eb, LY6G5Cb, BAG6b, GTF2H4b, HSPA1Lb, ABHD16Ab, GPANK1b, PRRC2Ab, C2b, TCF19b, SLC44A4b, CLIC1b, EHMT2b, VARSb, C6orf47b, CFBb, NEU1b, LSM2b, C6orf48b, MSH5b, ZBTB12b, C4Ac, CYP21A2c, FLOT1c, C4Bc, PPP1R18c, PSORS1C1c, HLA-DQA1c, HLA-DQB1c, OR5V1c, IER3c, NOTCH4c, LY6G6Cc, RNF5c, TMEM154d, HIST1H2BDc, CSF3Rd, C6orf10c, HLA-Gc, BTN3A2c, HLA-DPB1c, SKIV2Lc |
rs3094005 6:31,465,047 |
4.2×10-38 replicable replicated |
|
safety |
106 Top |
Protein C (trans) Vitamin K-dependent protein C |
TRPC4APabc, EDEM2abc, PROCRace, GSSab, MYH7Bab [18 more]ACSS2bc, MMP24bc, CPNE1bc, EIF6bc, GDF5OSb, CEP250b, C20orf173b, PIGUb, ERGIC3b, NFS1b, GGT7b, TP53INP2b, RBM12b, NCOA6b, SPAG4b, MAP1LC3Ac, UQCC1c, RBL1c |
rs867186 20:33,764,554 |
5.4×10-38 replicable replicated |
|
diagnosis, efficacy |
107 Top |
MMP-12 (cis) Macrophage metalloelastase |
MMP3ab, MMP12a, DYNC2H1b, MMP20b |
rs17368582 11:102,738,075 |
1.5×10-37 replicable replicated |
marimastat |
efficacy, unspecified application |
108 Top |
IMDH1 (trans) Inosine-5'-monophosphate dehydrogenase 1 |
ANKRD9abc, TECPR2ac, CINPc, ZNF839c |
rs1190552 14:102,911,907 |
1.5×10-37 replicable |
thioguanine, VX-944, pegintron/ribavirin, PEG-interferon alfa-2a/ribavirin, nitazoxanide/peginterferon alfa-2a/ribavirin, interferon alfa-2b/ribavirin, mycophenolate mofetil, mycophenolic acid, ribavirin |
|
109 Top |
Carbonic anhydrase 6 (cis) |
CA6a |
rs6697763 1:9,037,273 |
3×10-37 replicable replicated |
methazolamide, hydrochlorothiazide, acetazolamide, trichloromethiazide, chlorothiazide, chlorthalidone, benzthiazide, sulfacetamide, topiramate |
|
110 Top |
CYTN (cis) Cystatin-SN |
CST1ace, CST9Lb, CSTL1b, CST8b, CST11b [1 more]GGTLC1b |
rs6114248 20:23,711,882 |
5×10-37 replicable replicated |
|
|
110 |
CYTT (cis) Cystatin-SA |
CST1ace, CST9Lb, CSTL1b, CST8b, CST11b [1 more]GGTLC1b |
rs6114248 20:23,711,882 |
4.4×10-31 replicable replicated |
|
|
111 Top |
Factor H (cis) Complement factor H |
CFHac, CFHR1c, CFHR3c |
rs10737680 1:196,679,455 |
1.3×10-36 replicable replicated |
|
unspecified application |
112 Top |
Hemopexin (trans) |
CFHa |
rs419137 1:196,696,875 |
4.2×10-36 |
|
|
113 Top |
Mn SOD (trans) Superoxide dismutase [Mn], mitochondrial |
F12abc, GRK6a, RGS14c, RAB24c, MXD3c [1 more]GRIN2Bd |
rs2545801 5:176,841,339 |
4.6×10-36 |
|
diagnosis, unspecified application |
114 Top |
HGFA (cis) Hepatocyte growth factor activator |
RGS12a |
rs1203119 4:3,406,952 |
1.1×10-35 |
|
|
115 Top |
C1r (cis) Complement C1r subcomponent |
C1Sabce, C1RLc |
rs12146727 12:7,170,336 |
3.4×10-35 replicable replicated |
SERPING1 |
|
115 |
C1q (trans) Complement C1q subcomponent |
C1Sabce, C1RLc |
rs12146727 12:7,170,336 |
2×10-15 replicated |
|
|
116 Top |
ASAH2 (cis) Neutral ceramidase |
FAM21Ac |
rs2842126 10:52,018,482 |
5.7×10-34 replicable replicated |
|
|
117 Top |
TAFI (cis) Carboxypeptidase B2 |
LCP1bc, ZC3H13a, CPB2a, LRRC63b |
rs9534288 13:46,605,441 |
1.1×10-33 replicable replicated |
|
|
118 Top |
DAF (cis) Complement decay-accelerating factor |
CD55ac, IL20b, PIGRb, C4BPBb, CR1c |
rs12134133 1:207,457,845 |
1.6×10-33 replicable replicated |
|
|
119 Top |
MP2K2 (trans) Dual specificity mitogen-activated protein kinase kinase 2 |
PROZabc, PCID2abc, CUL4Aabc, ADPRHL1b, TMCO3b [9 more]ATP11Ab, ATP4Bb, MCF2Lb, DCUN1D2b, F7b, GRTP1b, TFDP1b, F10c, ADAMDEC1d |
rs556990 13:113,845,059 |
2.2×10-33 replicable |
selumetinib, trametinib, dabrafenib/trametinib |
|
120 Top |
ARTS1 (cis) Endoplasmic reticulum aminopeptidase 1 |
CASTac, ERAP1c |
rs149313 5:96,070,205 |
4.2×10-33 replicable replicated |
|
|
121 Top |
SAA (cis) Serum amyloid A-1 protein |
HPS5abc, GTF2H1abc, LDHAbc, TSG101b, UEVLDb [2 more]SAA1c, LDHCc |
rs4150579 11:18,357,180 |
5.5×10-33 replicable replicated |
|
diagnosis, unspecified application |
122 Top |
DLRB1 (trans) Dynein light chain roadblock-type 1 |
TRIM58ae |
rs1339847 1:248,039,294 |
9.2×10-33 replicable replicated |
|
|
123 Top |
MMP-8 (trans) Neutrophil collagenase |
SKIV2Lac, C2a, XXbac-BPG116M5.17a, NELFEa, DXOa [1 more]STK19a |
rs9283893 6:31,897,219 |
1.2×10-32 replicable replicated |
marimastat |
efficacy |
124 Top |
Siglec-9 (cis) Sialic acid-binding Ig-like lectin 9 |
SIGLEC9a |
rs1568003 19:51,633,660 |
4.4×10-32 |
|
|
125 Top |
ILT-2 (cis) Leukocyte immunoglobulin-like receptor subfamily B member 1 |
LILRB1abce, LILRA1a, TMC4b, TTYH1b, TSEN34b [7 more]MBOAT7b, CNOT3b, NLRP2b, KIR3DX1b, LAIR2b, LAIR1b, LILRA4b |
rs45461791 19:55,112,396 |
5.5×10-32 replicable |
|
|
126 Top |
GPVI (cis) Platelet glycoprotein VI |
RDH13ac, GP6ac, NLRP2c |
rs1654439 19:55,553,647 |
6.6×10-31 replicable replicated |
|
|
127 Top |
IGF-II receptor (cis) Cation-independent mannose-6-phosphate receptor |
IGF2Rac, LPAb |
rs2297363 6:160,506,462 |
8.2×10-31 replicable replicated |
|
|
128 Top |
SREC-I (cis) Scavenger receptor class F member 1 |
PRPF8a |
rs8071756 17:1,574,342 |
9.4×10-31 replicable |
|
|
129 Top |
MMP-1 (cis) Interstitial collagenase |
MMP1ac, MMP27b, MMP3b, DYNC2H1b |
rs484915 11:102,673,248 |
2.1×10-30 replicable replicated |
marimastat |
diagnosis, efficacy, safety |
130 Top |
MSP (cis) Hepatocyte growth factor-like protein |
IP6K2abce, SLC26A6abce, NCKIPSDabc, CELSR3ace, TMEM89ac [25 more]WDR6bc, ATRIPbc, ARIH2b, ZNF589b, CDC25Ab, DALRD3b, QARSb, CCDC51b, QRICH1b, PLXNB1b, COL7A1b, SLC25A20b, SPINK8b, PRKAR2Ab, PFKFB4c, C3orf62c, UBA7c, USP4c, CCDC36c, KLHDC8Bc, TREX1c, TREX1c, NICN1c, RBM6c, CCDC71c |
rs13063312 3:48,661,985 |
4.4×10-30 replicable replicated |
|
|
131 Top |
Angiogenin (cis) |
RP11-903H12.5a, RNASE4a, ANGa, RNASE9c |
rs17114699 14:21,158,910 |
7.3×10-30 |
|
response to therapy |
132 Top |
MMP-8 (trans) Neutrophil collagenase |
|
rs2736186 6:31,572,333 |
1.1×10-29 |
marimastat |
efficacy |
133 Top |
Lysozyme (cis) Lysozyme C |
LYZabe |
rs1800973 12:69,744,014 |
2.4×10-29 |
|
unspecified application |
134 Top |
NAGK (cis) N-acetyl-D-glucosamine kinase |
NAGKabc, MPHOSPH10b, ZNF638b, CD207b, MCEEc |
rs6714900 2:71,325,355 |
3.8×10-29 replicable |
|
|
135 Top |
BGH3 (cis) Transforming growth factor-beta-induced protein ig-h3 |
TGFBIabc, SMAD5c, TRPC7c |
rs3792900 5:135,393,754 |
4.2×10-29 replicable replicated |
|
|
136 Top |
Siglec-6 (cis) Sialic acid-binding Ig-like lectin 6 |
SIGLEC6abe, SIGLEC12b, SIGLEC14b, SIGLEC10b, ZNF175c [1 more]LRRC4Bc |
rs2005199 19:52,033,206 |
5.1×10-29 replicable replicated |
|
|
137 Top |
C4b (cis) Complement C4b |
CYP21A2ace, NELFEac, DXOac, TNXBae, C2a [28 more]XXbac-BPG116M5.17a, CFBa, SKIV2La, STK19a, C4Aa, C4Ba, PRRT1b, LY6G5Cb, BTNL2b, HLA-DQB1c, HLA-Cc, AIF1c, HSPA1Bc, MSH5c, BAG6c, PRRC2Ac, HLA-Bc, VARS2c, ATF6Bc, HSPA1Lc, MSH5-SAPCD1c, EHMT2c, HLA-DQA2c, CCHCR1c, LST1c, NOTCH4c, AGPAT1c, HLA-DRB5c |
rs2280774 6:31,928,691 |
7.6×10-29 replicable replicated |
|
|
137 |
C34 gp41 HIV Fragment (trans) gp41 C34 peptide, HIV |
CYP21A2ace, NELFEac, DXOac, TNXBae, C2a [28 more]XXbac-BPG116M5.17a, CFBa, SKIV2La, STK19a, C4Aa, C4Ba, PRRT1b, LY6G5Cb, BTNL2b, HLA-DQB1c, HLA-Cc, AIF1c, HSPA1Bc, MSH5c, BAG6c, PRRC2Ac, HLA-Bc, VARS2c, ATF6Bc, HSPA1Lc, MSH5-SAPCD1c, EHMT2c, HLA-DQA2c, CCHCR1c, LST1c, NOTCH4c, AGPAT1c, HLA-DRB5c |
rs2280774 6:31,928,691 |
8.5×10-12 |
|
|
138 Top |
Prekallikrein (cis) Plasma kallikrein |
KLKB1ab, F11c, CYP4V2c |
rs1511802 4:187,150,806 |
9.1×10-29 replicable replicated |
aprotinin, ecallantide |
|
139 Top |
MIA (cis) Melanoma-derived growth regulatory protein |
C19orf54abc, MIAac, ADCK4a, ITPKCa, SNRPAa [3 more]MIA-RAB4Ba, RAB4Ba, RAB4B-EGLN2a |
rs1455434 19:41,257,046 |
1.7×10-28 replicable replicated |
|
disease progression, prognosis |
140 Top |
PDK1 (cis) [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial |
PDK1abc, ITGA6a, METAP1Db |
rs12052479 2:173,404,804 |
2.5×10-28 replicable |
dichloroacetic acid |
|
141 Top |
FCG3B (cis) Low affinity immunoglobulin gamma Fc region receptor III-B |
HSPA6ab, FCGR3Aa, USF1b, UFC1b, TOMM40Lb [2 more]FCRLBc, FCGR2Bc |
rs10919544 1:161,508,763 |
3.5×10-28 replicable replicated |
IgG |
|
141 |
FCG2A/B (cis) Low affinity immunoglobulin gamma Fc region receptor II-a/b |
HSPA6ab, FCGR3Aa, USF1b, UFC1b, TOMM40Lb [2 more]FCRLBc, FCGR2Bc |
rs10919544 1:161,508,763 |
6.4×10-21 replicable |
|
|
142 Top |
Factor B (cis) Complement factor B |
DXOac, C2ae, CFBae, EHMT2a, SLC44A4a [9 more]ZBTB12a, XXbac-BPG116M5.17a, NELFEa, STK19a, C4Aa, C6orf48c, XXbac-BPG246D15.9c, HLA-DOBc, HLA-Bc |
rs4151669 6:31,915,144 |
6.3×10-28 |
|
|
143 Top |
IL-5 Ra (cis) Interleukin-5 receptor subunit alpha |
IL5RAae |
rs2290610 3:3,139,957 |
7.6×10-28 replicable replicated |
|
|
144 Top |
sFRP-3 (cis) Secreted frizzled-related protein 3 |
FRZBae |
rs288326 2:183,703,336 |
8.6×10-28 replicable replicated |
|
|
145 Top |
Cathepsin B (cis) |
FDFT1abc, CTSBabc, FAM167Abc, BLKb, DEFB130b [2 more]DEFB130b, ANTXR1d |
rs3947 8:11,702,375 |
1.5×10-27 replicable |
|
|
146 Top |
MICB (cis) MHC class I polypeptide-related sequence B |
MICBabc, LST1abc, DDX39Bab, ATP6V1G2ab, TNFab [36 more]NCR3ab, PRRC2Aab, CSNK2Bab, GPANK1ab, LY6G5Bab, CLIC1ab, MSH5ab, VARSab, MICAbc, MCCD1a, ATP6V1G2-DDX39Ba, NFKBIL1a, LTBa, LTAa, BAG6a, CSNK2B-LY6G5B--991a, C6orf47a, MSH5-SAPCD1a, HLA-Cb, HLA-Bb, HCG27b, LY6G5Cb, C4Ab, C2b, EHMT2b, CFBb, C6orf48b, LSM2b, ZBTB12b, AIF1b, STK19b, NOTCH4c, PSORS1C2c, DDR1c, CDSNc, RNF5c |
rs2905736 6:31,453,290 |
1.8×10-27 |
|
safety |
147 Top |
TPSB2 (cis) Tryptase beta-2 |
TPSD1abc, TPSG1ac, TPSB2ac, TPSAB1ac, CACNA1Ha [1 more]CHTF18b |
rs4984778 16:1,297,516 |
2.7×10-27 replicable replicated |
|
|
148 Top |
PLXC1 (cis) Plexin-C1 |
PLXNC1a |
rs2361355 12:94,630,029 |
8.6×10-27 replicable replicated |
|
|
149 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
MICAabc, VARS2b, PSORS1C2c, CCHCR1c, HLA-Bc [1 more]PSORS1C1c |
rs17206736 6:31,389,768 |
1.3×10-26 |
|
safety |
150 Top |
b-Endorphin (trans) Beta-endorphin |
SIK3ab, SIDT2bc, PCSK7b, BUD13b, RNF214b [2 more]CEP164b, APOA1c |
rs12099358 11:116,726,048 |
1.6×10-26 replicable replicated |
|
diagnosis, efficacy, unspecified application |
151 Top |
BST1 (cis) ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 |
BST1abce, FBXL5ab, CC2D2Aa, FAM200Ba |
rs7657257 4:15,646,941 |
1.6×10-26 replicable replicated |
|
|
152 Top |
PD-L2 (cis) Programmed cell death 1 ligand 2 |
PDCD1LG2ac, KIAA2026b |
rs16923189 9:5,510,644 |
1.6×10-26 replicable replicated |
|
|
153 Top |
Semaphorin 3E (cis) Semaphorin-3E |
SEMA3Eac |
rs536299 7:83,267,983 |
2.2×10-26 replicable replicated |
|
|
154 Top |
PDGF Rb (cis) Platelet-derived growth factor receptor beta |
PDGFRBac, CSF1Rc |
rs3756309 5:149,505,624 |
2.5×10-26 replicable replicated |
nilotinib, dasatinib, sunitinib, pazopanib, axitinib, tivozanib, tandutinib, nintedanib, regorafenib, bortezomib/sorafenib, lapatinib/pazopanib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, imatinib/sirolimus, imatinib, sorafenib, becaplermin |
prognosis, response to therapy, unspecified application |
155 Top |
MP2K2 (trans) Dual specificity mitogen-activated protein kinase kinase 2 |
PROZac, PCID2a, CUL4Aa |
rs515863 13:113,839,747 |
2.5×10-26 replicable replicated |
selumetinib, trametinib, dabrafenib/trametinib |
|
156 Top |
PPID (cis) Peptidyl-prolyl cis-trans isomerase D |
PPIDace, ETFDHac |
rs8396 4:159,630,817 |
3.4×10-26 replicable |
|
|
157 Top |
Alkaline phosphatase, bone (trans) Alkaline phosphatase, tissue-nonspecific isozyme |
LTFabe, CCR5b, CCR3c |
rs1126478 3:46,501,213 |
5.1×10-26 replicable replicated |
|
efficacy, safety |
158 Top |
P-Selectin (cis) |
F5ac, SELPae |
rs6136 1:169,563,951 |
1.1×10-25 |
|
efficacy, safety, unspecified application |
159 Top |
C34 gp41 HIV Fragment (trans) gp41 C34 peptide, HIV |
SKIV2Lace, C4Bac, TNXBab, DXOa, STK19a [20 more]C4Aa, AL645922.1a, CYP21A2a, EHMT2b, GPSM3b, NCR3b, C6orf25b, LY6G6Cb, AGERb, LST1b, AIF1b, ABHD16Ab, LY6G5Cb, PPT2b, VARSb, SLC44A4b, EGFL8b, NELFEc, LSM2c, HSPA1Lc |
rs387608 6:31,941,557 |
2.5×10-25 replicable replicated |
|
|
160 Top |
HRG (cis) Histidine-rich glycoprotein |
FETUBa, HRGa |
rs2555515 3:186,388,028 |
2.8×10-25 replicable |
|
|
161 Top |
Catalase (cis) |
CATac, ELF5a, NAT10b, CAPRIN1b, ABTB2c |
rs2284367 11:34,484,542 |
4.1×10-25 replicable |
fomepizole |
diagnosis |
162 Top |
CDON (cis) Cell adhesion molecule-related/down-regulated by oncogenes |
CDONae |
rs3740909 11:125,889,526 |
4.4×10-25 replicable replicated |
|
|
163 Top |
sL-Selectin (cis) L-Selectin |
C1orf112ac, SELLac |
rs12938 1:169,660,781 |
4.5×10-25 replicable replicated |
|
efficacy |
164 Top |
Coagulation Factor XI (cis) |
F11a, IRF2c |
rs2289252 4:187,207,381 |
4.6×10-25 replicable replicated |
|
|
165 Top |
Coagulation Factor V (cis) |
F5ae |
rs6033 1:169,521,853 |
5.5×10-25 replicable replicated |
drotrecogin alfa, antithrombin alfa |
diagnosis |
166 Top |
Semaphorin 3E (cis) Semaphorin-3E |
|
rs3109167 7:82,977,124 |
9.1×10-25 replicable |
|
|
167 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
MICAabc, HLA-Bbc, LY6G5Cbc, LTBb, CSNK2Bb [14 more]DDX39Bb, BAG6b, HCG27b, LST1b, AIF1b, MICBb, ABHD16Ab, GPANK1b, HLA-Cb, C2b, VARSb, TNFb, C6orf48b, PRRC2Ab |
rs9469012 6:31,421,300 |
9.6×10-25 replicable replicated |
|
safety |
168 Top |
IL-18 Rb (cis) Interleukin-18 receptor accessory protein |
IL18R1ac, IL18RAPac, SLC9A4ab, IL1R2b, SLC9A2b [1 more]IL1RL1c |
rs6543140 2:103,074,274 |
1×10-24 replicable |
|
|
169 Top |
Chitotriosidase-1 (cis) |
CHIT1ae |
rs4950937 1:203,182,292 |
1.4×10-24 replicable replicated |
|
efficacy |
170 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
HLA-Cac, MICAac, HLA-Ba, SLC44A4b, CCHCR1b [8 more]TCF19b, VARS2b, HCG27c, ATP6V1G2-DDX39Bc, DDX39Bc, POU5F1c, MICBc, LY6G5Cc |
rs2524280 6:31,416,990 |
2.6×10-24 replicable |
|
safety |
171 Top |
PPIE (cis) Peptidyl-prolyl cis-trans isomerase E |
PPIEabc, BMP8Bac, MACF1b, OXCT2c |
rs9787249 1:40,212,878 |
8.9×10-24 replicable |
|
|
172 Top |
Coagulation Factor V (cis) |
F5ae |
rs9332701 1:169,484,767 |
1.2×10-23 |
drotrecogin alfa, antithrombin alfa |
diagnosis |
173 Top |
Hemopexin (trans) |
CRB1a |
rs2786107 1:197,310,777 |
1.4×10-23 replicable |
|
|
174 Top |
NKp30 (cis) Natural cytotoxicity triggering receptor 3 |
LST1abc, NCR3abc, ATP6V1G2ac, TNFab, AIF1bc [20 more]MICAbc, HLA-Bbc, MICBbc, NFKBIL1a, LTAa, LTBa, HLA-Cb, CSNK2Bb, DDX39Bb, C6orf48b, PRRC2Ab, LY6G5Cb, GPANK1b, STK19b, C2b, VARSb, HCG27b, MSH5b, BAG6c, PSORS1C1c |
rs6916921 6:31,520,426 |
2.2×10-23 replicable replicated |
|
|
175 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
ATP6V1G2c, HCG27c, LST1c, LY6G5Cc, C4Ac [5 more]NOTCH4c, MICAc, PRRC2Ac, HLA-Bc, MICBc |
rs2516470 6:31,407,331 |
4.5×10-23 |
|
safety |
176 Top |
SLAF7 (cis) SLAM family member 7 |
ITLN1ab, CD244a, USF1b, SLAMF7b, TOMM40Lb [7 more]PPOXb, NIT1b, MPZb, SLAMF1b, ARHGAP30b, FCER1Gb, USP21b |
rs11578770 1:160,845,636 |
7.5×10-23 |
|
|
177 Top |
Properdin (trans) |
CFHace, CFHR1c, CFHR3c |
rs7529589 1:196,658,279 |
2.4×10-22 replicable |
|
|
178 Top |
IGFBP-3 (cis) Insulin-like growth factor-binding protein 3 |
IGFBP3c |
rs2949833 7:45,984,820 |
2.6×10-22 replicable replicated |
|
diagnosis, disease progression, efficacy, prognosis, safety |
178 |
IGF-I (trans) Insulin-like growth factor I |
IGFBP3c |
rs2949833 7:45,984,820 |
3×10-12 |
|
diagnosis, efficacy, prognosis, safety |
179 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
HLA-Babc, HLA-Cab, CSNK2Bb, DDX39Bb, VARSb [12 more]GTF2H4b, VARS2b, DDR1b, TNFb, LST1b, PRRC2Ab, MICBb, LY6G5Cb, GPANK1b, PSORS1C1b, FLOT1c, SKIV2Lc |
rs2523570 6:31,329,734 |
2.7×10-22 replicable |
|
safety |
180 Top |
MICB (cis) MHC class I polypeptide-related sequence B |
RNF39abc, TRIM31abc, FLOT1abc, PPP1R18ace, ZNRD1ac [38 more]TRIM26ab, TRIM39-RPP21ac, RPP21ac, ATAT1ab, NRMab, IER3ac, PPP1R11a, TRIM40a, TRIM10a, TRIM15a, TRIM39a, GNL1a, ABCF1a, PPP1R10a, MRPS18Ba, C6orf136a, DHX16a, TUBBa, MDC1a, DDR1b, ZFP57c, HLA-Gc, HLA-Cc, BTN3A2c, HLA-Ac, BTN3A3c, HIST1H3Ic, NDUFS1d, TMEM154d, CCHCR1c, PSORS1C1c, CFBc, C2c, VARS2c, GABBR1c, MICBc, OR5V1c, HLA-Bc |
rs3132645 6:30,409,249 |
3.9×10-22 replicable |
|
safety |
181 Top |
Haptoglobin, Mixed Type (cis) Haptoglobin |
IST1a, PKD1L3a, AP1G1c, PHLPP2c, HPc |
rs17286411 16:71,968,701 |
4.9×10-22 replicable replicated |
|
diagnosis, efficacy, unspecified application |
182 Top |
RAP (trans) alpha-2-macroglobulin receptor-associated protein |
TAP2a, PSMB9a, XXbac-BPG246D15.9a, TAP1a, PSMB8a [3 more]HLA-DOBb, COL11A2b, HLA-DPB1b |
rs17220241 6:32,822,244 |
9.6×10-22 replicable replicated |
|
|
183 Top |
IL-7 Ra (cis) Interleukin-7 receptor subunit alpha |
IL7Ra |
rs11957503 5:35,883,176 |
1.9×10-21 replicable replicated |
recombinant human interleukin-7 |
|
184 Top |
TSG-6 (cis) Tumor necrosis factor-inducible gene 6 protein |
RBM43ac, NMIac, RIF1c, TNFAIP6c |
rs289828 2:152,137,181 |
2.1×10-21 replicable replicated |
|
unspecified application |
185 Top |
sTie-2 (cis) Angiopoietin-1 receptor, soluble |
TEKabe |
rs35030851 9:27,197,486 |
4.1×10-21 replicable replicated |
cabozantinib, regorafenib, ponatinib, cabozantinib/erlotinib, vandetanib |
efficacy |
186 Top |
VEGF sR2 (cis) Vascular endothelial growth factor receptor 2 |
KDRae |
rs34231037 4:55,972,946 |
4.5×10-21 |
AEE 788, sunitinib, cediranib, pazopanib, axitinib, XL647, CEP 7055, brivanib alaninate, CHIR-265, tivozanib, motesanib, OSI-930, telatinib, ramucirumab, cabozantinib, nintedanib, regorafenib, bortezomib/sorafenib, lapatinib/pazopanib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, cabozantinib/erlotinib, docetaxel/ramucirumab, vatalanib, sorafenib, vandetanib, pegaptanib |
disease progression, efficacy, prognosis, response to therapy, safety |
187 Top |
IP-10 (cis) C-X-C motif chemokine 10 |
CXCL10ae, ART3a |
rs11548618 4:76,943,947 |
4.9×10-21 |
MDX-1100 |
diagnosis, efficacy, unspecified application |
188 Top |
CLM6 (trans) CMRF35-like molecule 6 |
POC1Bac, POC1B-GALNT4ac, GALNT4ac, ATP2B1c |
rs10858881 12:89,891,474 |
5.1×10-21 replicable |
|
|
189 Top |
TECK (cis) C-C motif chemokine 25 |
FBN3ae, ELAVL1a |
rs3848570 19:8,145,928 |
7.6×10-21 |
|
disease progression |
190 Top |
Fucosyltransferase 3 (cis) Galactoside 3(4)-L-fucosyltransferase |
FUT3ae |
rs28362459 19:5,844,792 |
1.1×10-20 replicated |
|
|
191 Top |
ATS13 (cis) A disintegrin and metalloproteinase with thrombospondin motifs 13 |
SURF2abc, SURF1abc, REXO4abc, SURF6ac, MED22ac [8 more]ADAMTS13ac, RPL7Aa, SURF4a, AK8b, SARDHb, GTF3C5b, CACFD1c, SLC2A6c |
rs3118663 9:136,281,753 |
1.4×10-20 replicable replicated |
|
|
192 Top |
HAI-1 (trans) Kunitz-type protease inhibitor 1 |
RP5-864K19.6ace, GJA9ace, RHBDL2ace, RRAGCab, MYCBPac [1 more]MACF1b |
rs4494114 1:39,339,682 |
1.9×10-20 replicated |
|
|
193 Top |
TIMP-3 (cis) Metalloproteinase inhibitor 3 |
SYN3a, TIMP3a |
rs241890 22:33,242,162 |
2.6×10-20 replicable replicated |
|
diagnosis, prognosis, unspecified application |
194 Top |
MBL (cis) Mannose-binding protein C |
sentinel not in SNiPA's database
|
rs5784945 10:54,544,242 |
4.2×10-20 replicable replicated |
|
diagnosis |
195 Top |
BST1 (cis) ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 |
FBXL5abc, CC2D2Aac, FAM200Ba, BST1b, C1QTNF7c |
rs1789 4:15,664,535 |
4.5×10-20 replicable replicated |
|
|
196 Top |
LY9 (cis) T-lymphocyte surface antigen Ly-9 |
LY9ac, SLAMF7c |
rs540254 1:160,767,737 |
7.8×10-20 |
|
|
197 Top |
Carbonic anhydrase XIII (cis) Carbonic anhydrase 13 |
E2F5abe, CA1ab, CA3ab, C8orf59a, CA13a [1 more]LRRCC1c |
rs17741049 8:86,198,253 |
7.9×10-20 |
methazolamide, hydrochlorothiazide, acetazolamide, trichloromethiazide, chlorothiazide, chlorthalidone, benzthiazide, sulfacetamide, topiramate |
|
198 Top |
MICB (cis) MHC class I polypeptide-related sequence B |
LY6G6Db, SLC44A4b, LY6G6Eb, CCHCR1b, ATP6V1G2c [9 more]HCG27c, LY6G5Cc, PSORS1C2c, HLA-Cc, MICAc, HLA-Bc, MICBc, PSORS1C1c, LST1c |
rs2248372 6:31,446,466 |
9.7×10-20 replicable replicated |
|
safety |
199 Top |
MICB (cis) MHC class I polypeptide-related sequence B |
GABBR1abc, OR12D3abe, TRIM27ab, OR2B3ab, ZNF311a [30 more]OR2W1a, OR2J3a, OR2J2a, OR14J1a, OR5V1a, OR10C1a, OR11A1a, OR2H1a, MAS1La, UBDa, GPX5b, GPX6b, ZFP57c, ZSCAN26c, ZSCAN23c, HIST1H4Jc, HIST1H3Jc, HLA-Cc, ZSCAN31c, HLA-Gc, BTN3A3c, BTN3A2c, ZNF165c, ABT1c, HLA-Ac, TRIM31c, SLC44A4c, ZNRD1c, C2c, CFBc |
rs3129682 6:29,283,672 |
1.3×10-19 replicable |
|
safety |
199 |
MICA (cis) MHC class I polypeptide-related sequence A |
GABBR1abc, OR12D3abe, TRIM27ab, OR2B3ab, ZNF311a [30 more]OR2W1a, OR2J3a, OR2J2a, OR14J1a, OR5V1a, OR10C1a, OR11A1a, OR2H1a, MAS1La, UBDa, GPX5b, GPX6b, ZFP57c, ZSCAN26c, ZSCAN23c, HIST1H4Jc, HIST1H3Jc, HLA-Cc, ZSCAN31c, HLA-Gc, BTN3A3c, BTN3A2c, ZNF165c, ABT1c, HLA-Ac, TRIM31c, SLC44A4c, ZNRD1c, C2c, CFBc |
rs3131085 6:29,044,701 |
9.7×10-10 |
|
safety |
200 Top |
Factor B (cis) Complement factor B |
SKIV2Labce, CFBab, NELFEac, C2a, XXbac-BPG116M5.17a [2 more]PRRT1c, NEU1c |
rs550513 6:31,920,687 |
1.3×10-19 replicated |
|
|
201 Top |
Cathepsin S (cis) |
CTSSabce, CTSKabc, ARNTabc, HORMAD1ace, GOLPH3Lac [11 more]SETDB1bc, ADAMTSL4bc, BNIPLb, SEMA6Cb, PRPF3b, PIP5K1Ab, MCL1b, TARS2b, CERS2c, ANXA9c, CDC42SE1c |
rs1336900 1:150,679,033 |
1.4×10-19 replicable replicated |
|
|
202 Top |
Ck-b-8-1 (cis) Ck-beta-8-1 |
CCL23ace, CCL15-CCL14ac, CCL15a, CCL14c |
rs1003645 17:34,340,284 |
1.6×10-19 replicated |
|
|
203 Top |
Endothelin-converting enzyme 1 (trans) |
PCOLCE2ac, U2SURPb, ATRb, PLS1b |
rs4683702 3:142,617,138 |
2×10-19 replicable replicated |
|
|
204 Top |
GFRa-2 (cis) GDNF family receptor alpha-2 |
GFRA2ac |
rs4443656 8:21,541,084 |
2.2×10-19 replicable replicated |
|
|
205 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
CLIC1a, MSH5-SAPCD1a, MSH5a, SAPCD1a, VARSa [13 more]VWA7a, SKIV2Lc, NELFEc, LY6G5Cc, AIF1c, HSPA1Bc, DXOc, TNFc, LY6G6Cc, PRRC2Ac, C6orf48c, ATF6Bc, BAG6c |
rs3828922 6:31,713,454 |
2.3×10-19 |
|
safety |
205 |
C34 gp41 HIV Fragment (trans) gp41 C34 peptide, HIV |
CLIC1a, MSH5-SAPCD1a, MSH5a, SAPCD1a, VARSa [13 more]VWA7a, SKIV2Lc, NELFEc, LY6G5Cc, AIF1c, HSPA1Bc, DXOc, TNFc, LY6G6Cc, PRRC2Ac, C6orf48c, ATF6Bc, BAG6c |
rs2075801 6:31,728,267 |
7.9×10-15 |
|
|
205 |
C4 (cis) Complement C4 |
CLIC1a, MSH5-SAPCD1a, MSH5a, SAPCD1a, VARSa [13 more]VWA7a, SKIV2Lc, NELFEc, LY6G5Cc, AIF1c, HSPA1Bc, DXOc, TNFc, LY6G6Cc, PRRC2Ac, C6orf48c, ATF6Bc, BAG6c |
rs409558 6:31,708,147 |
1.2×10-10 |
|
|
206 Top |
MICB (cis) MHC class I polypeptide-related sequence B |
BTNL2ab, XXbac-BPG246D15.9ac, C6orf10a, HLA-DRAa, HLA-DOBa [22 more]C2b, EGFL8b, HLA-DQA1c, HLA-DQB2c, TNXBc, C4Ac, HLA-Cc, CYP21A2c, MICBc, HLA-DMBc, STK19c, HLA-DRB5c, RNF5c, NOTCH4c, HLA-DMAc, C4Bc, LY6G6Cc, VARS2c, PSMB9c, HLA-DPB1c, HLA-DQB1c, TAP2c |
rs1794282 6:32,666,526 |
2.6×10-19 replicable |
|
safety |
207 Top |
RET (cis) Proto-oncogene tyrosine-protein kinase receptor Ret |
RETabc, HNRNPFb, BMS1b, RASGEF1Ab, ZNF239b [2 more]CSGALNACT2c, ZNF33Bc |
rs2505535 10:43,593,043 |
2.8×10-19 replicated |
sunitinib, motesanib, cabozantinib, regorafenib, ponatinib, bortezomib/sorafenib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, imatinib/sirolimus, cabozantinib/erlotinib, imatinib/nilotinib/pegintron, imatinib, sorafenib, vandetanib |
efficacy, response to therapy |
208 Top |
SIRT2 (trans) NAD-dependent protein deacetylase sirtuin-2 |
APOHae, PRKCAa |
rs1801689 17:64,210,580 |
2.8×10-19 |
|
|
208 |
Dkk-4 (trans) Dickkopf-related protein 4 |
APOHae, PRKCAa |
rs1801689 17:64,210,580 |
7×10-10 |
|
|
209 Top |
PPAC (cis) Low molecular weight phosphotyrosine protein phosphatase |
SH3YL1ac, FAM150Ba, ACP1a |
rs300756 2:233,416 |
3×10-19 replicable replicated |
|
|
210 Top |
NXPH1 (trans) Neurexophilin-1 |
C1orf168bc, C8Aa, C8Ba, DAB1b |
rs626457 1:57,407,484 |
3.3×10-19 replicable replicated |
|
|
210 |
I-309 (trans) C-C motif chemokine 1 |
C1orf168bc, C8Aa, C8Ba, DAB1b |
rs626457 1:57,407,484 |
2.7×10-9 |
|
|
211 Top |
CYTN (cis) Cystatin-SN |
CST1ace |
rs2070856 20:23,731,412 |
5.6×10-19 |
|
|
212 Top |
SIRT2 (trans) NAD-dependent protein deacetylase sirtuin-2 |
APOHae, CEP112a |
rs8178847 17:64,216,815 |
8.2×10-19 replicable |
|
|
212 |
Dkk-4 (trans) Dickkopf-related protein 4 |
APOHae, CEP112a |
rs8178847 17:64,216,815 |
4.1×10-17 replicable |
|
|
213 Top |
TSP2 (cis) Thrombospondin-2 |
THBS2b, WDR27b |
rs3763267 6:169,571,693 |
8.6×10-19 |
|
|
214 Top |
Spondin-1 (cis) |
SPON1abc, COPB1b, RRAS2b |
rs10832169 11:14,066,486 |
8.7×10-19 replicated |
|
|
215 Top |
Calpain I (cis) |
SYVN1ab, SPDYCac, VPS51a, TM7SF2a, MRPL49a [6 more]SIPA1b, SAC3D1b, MEN1b, CDCA5b, ARL2c, NAALADL1c |
rs10895987 11:64,904,908 |
1×10-18 |
|
|
216 Top |
HCC-1 (cis) C-C motif chemokine 14 |
RDM1a, LYZL6a |
rs17676662 17:34,262,254 |
1.2×10-18 |
|
|
217 Top |
EDAR (cis) Tumor necrosis factor receptor superfamily member EDAR |
EDARab, LIMS1b, SULT1C3c |
rs6750059 2:109,611,097 |
1.3×10-18 replicable |
|
|
218 Top |
PPase (cis) Inorganic pyrophosphatase |
PPA1ac, NPFFR1a, SAR1Ac, AIFM2c, EIF4EBP2c [1 more]TYSND1c |
rs10823500 10:72,005,190 |
1.5×10-18 |
|
|
219 Top |
SIG14 (cis) Sialic acid-binding Ig-like lectin 14 |
SIGLEC5a, SIGLEC5a, SIGLEC14c |
rs6509558 19:52,127,949 |
2.2×10-18 |
|
|
220 Top |
Contactin-5 (cis) |
CNTN5a |
rs1461672 11:99,175,378 |
2.2×10-18 replicable |
|
|
221 Top |
Siglec-3 (cis) Myeloid cell surface antigen CD33 |
ETFBc, CD33c |
rs1710354 19:51,802,140 |
2.3×10-18 replicable |
arsenic trioxide/gemtuzumab ozogamicin/tretinoin, gemtuzumab ozogamicin |
efficacy |
222 Top |
MIA (cis) Melanoma-derived growth regulatory protein |
CTC-490E21.12a, CYP2A6a, CYP2A7a |
rs4803378 19:41,333,441 |
2.5×10-18 |
|
disease progression, prognosis |
223 Top |
Siglec-3 (cis) Myeloid cell surface antigen CD33 |
|
rs10421385 19:51,701,891 |
2.9×10-18 |
arsenic trioxide/gemtuzumab ozogamicin/tretinoin, gemtuzumab ozogamicin |
efficacy |
224 Top |
DAPK2 (cis) Death-associated protein kinase 2 |
DAPK2ac |
rs922182 15:64,277,642 |
3.1×10-18 replicable |
|
|
225 Top |
TIMP-3 (cis) Metalloproteinase inhibitor 3 |
SYN3a |
rs135150 22:33,170,101 |
4.4×10-18 |
|
diagnosis, prognosis, unspecified application |
226 Top |
ENTP5 (cis) Ectonucleoside triphosphate diphosphohydrolase 5 |
ALDH6A1ac, LIN52ac, CCDC176ae, ENTPD5a, COQ6c [1 more]PTGR2c |
rs7160336 14:74,572,360 |
6×10-18 replicated |
|
|
227 Top |
ART (cis) Agouti-related protein |
ZDHHC1abc, HSD11B2abc, ATP6V0D1abc, LRRC36ace, AGRPace [25 more]TPPP3ab, FAM65Aab, EXOC3L1bc, LCATbc, C16orf86bc, TRADDbc, KCTD19ae, SLC9A5a, PLEKHG4a, CES4Ab, HSF4b, EDC4b, ELMO3b, FBXL8b, CBFBb, C16orf70b, NUTF2b, GFOD2b, SLC12A4b, RANBP10c, DPEP2c, DUS2c, PLA2G15c, NFATC3c, CTCFc |
rs7184253 16:67,380,550 |
6.7×10-18 replicable |
|
unspecified application |
228 Top |
IL-1 R4 (cis) Interleukin-1 receptor-like 1 |
IL18RAPa, IL18R1b |
rs12997015 2:103,042,401 |
7.7×10-18 |
|
|
229 Top |
C7 (cis) Complement component C7 |
PLCXD3bc, C6a, C7c |
rs429017 5:41,263,091 |
9×10-18 |
|
|
230 Top |
Factor I (cis) Complement factor I |
PLA2G12Aac, CFIab, CASP6c |
rs7439493 4:110,656,730 |
1.6×10-17 |
|
|
231 Top |
IL-1 R AcP (cis) Interleukin-1 Receptor accessory protein |
IL1RAPa |
rs2193873 3:190,313,507 |
1.7×10-17 |
|
|
232 Top |
ASM3A (cis) Acid sphingomyelinase-like phosphodiesterase 3a |
SMPDL3Aabce |
rs28385609 6:123,122,464 |
1.7×10-17 |
|
|
233 Top |
SAA (cis) Serum amyloid A-1 protein |
LDHCab, LDHAL6Aac, TSG101b, SERGEFb, UEVLDb [3 more]LDHAb, GTF2H1b, SPTY2D1b |
rs16935432 11:18,470,487 |
1.9×10-17 replicable replicated |
|
diagnosis, unspecified application |
234 Top |
EDAR (cis) Tumor necrosis factor receptor superfamily member EDAR |
EDARa |
rs260692 2:109,581,319 |
2.1×10-17 |
|
|
235 Top |
C4 (cis) Complement C4 |
ATF6Bac, TNXBa, TAP2c, XXbac-BPG246D15.9c, FKBPLc [1 more]MICBc |
rs8283 6:32,083,300 |
2.3×10-17 replicated |
|
|
236 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
|
rs1265047 6:31,081,464 |
2.4×10-17 |
|
safety |
237 Top |
IMDH2 (trans) Inosine-5'-monophosphate dehydrogenase 2 |
ZNF839ac, CINPac, TECPR2ac, ANKRD9c |
rs1005776 14:102,896,673 |
3.2×10-17 |
thioguanine, VX-944, pegintron/ribavirin, interferon alfa-2b/ribavirin, mycophenolate mofetil, mycophenolic acid, ribavirin |
|
238 Top |
ARTS1 (cis) Endoplasmic reticulum aminopeptidase 1 |
LIX1b, ERAP2c, CASTc, LNPEPc |
rs12520053 5:96,167,485 |
3.6×10-17 |
|
|
239 Top |
IGFBP-7 (cis) Insulin-like growth factor-binding protein 7 |
IGFBP7a, POLR2Bb |
rs2412776 4:57,951,468 |
5.5×10-17 |
|
|
240 Top |
FCG2A/B (cis) Low affinity immunoglobulin gamma Fc region receptor II-a/b |
FCGR2Bac, FCRLAac, FCGR3Bc, FCRLBc, HSPA6c |
rs6668534 1:161,671,995 |
6×10-17 |
|
|
241 Top |
FCN1 (cis) Ficolin-1 |
OLFM1c, FCN1c, NELFBc |
rs10858300 9:137,842,500 |
6.2×10-17 replicated |
|
|
242 Top |
RAP (trans) alpha-2-macroglobulin receptor-associated protein |
MOGab, ZFP57a, PPP1R11b, HLA-Fb, HLA-Ab [1 more]GABBR1b |
rs9468569 6:29,623,315 |
9.6×10-17 |
|
|
243 Top |
PCSK7 (cis) Proprotein convertase subtilisin/kexin type 7 |
SIK3ac, BACE1b, TAGLNc, APOA1c, PCSK7c [2 more]SIDT2c, BUD13c |
rs4938330 11:116,928,514 |
9.9×10-17 replicated |
|
unspecified application |
244 Top |
CPNE1 (cis) Copine-1 |
UQCC1ac, GDF5ac, ERGIC3bc, CPNE1bc, CEP250bc [13 more]GDF5OSa, MYH7Bb, NFS1b, ACSS2b, ROMO1b, TRPC4APb, GSSb, RBM12b, FAM83Cc, EIF6c, GGT7c, PROCRc, EDEM2c |
rs1204656 20:33,982,846 |
1×10-16 replicated |
|
|
245 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
NOTCH4ac, HLA-DQB1bc, GPSM3a, ATF6Bb, C2b [23 more]STK19b, VARSb, HLA-DQA1b, HLA-DRB1b, C6orf48b, AGPAT1b, PBX2b, SKIV2Lb, HLA-DRAb, HLA-DQB2c, C4Ac, HLA-Cc, HLA-Ec, CYP21A2c, BTN3A2c, MICBc, VARS2c, HCG27c, HLA-DRB5c, RNF5c, HLA-DMAc, C4Bc, HLA-DPB1c |
rs3134942 6:32,168,771 |
1.2×10-16 |
|
safety |
246 Top |
C7 (cis) Complement component C7 |
C7ae |
rs13157656 5:40,964,852 |
1.3×10-16 replicated |
|
|
247 Top |
IL-18 Ra (cis) Interleukin-18 receptor 1 |
SLC9A4a, IL18RAPc |
rs2871473 2:103,107,280 |
1.4×10-16 |
|
|
248 Top |
CYTT (cis) Cystatin-SA |
CST4ab, CST1ac, CSTL1b, CST8b, CST11b [2 more]GGTLC1b, CST3c |
rs7263120 20:23,690,021 |
2.3×10-16 replicated |
|
|
248 |
CYTN (cis) Cystatin-SN |
CST4ab, CST1ac, CSTL1b, CST8b, CST11b [2 more]GGTLC1b, CST3c |
rs7263120 20:23,690,021 |
9.6×10-13 |
|
|
249 Top |
TIG2 (cis) Retinoic acid receptor responder protein 2 |
LRRC61ac, ZBED6CLac, RARRES2c, REPIN1c, ACTR3Cc |
rs9640161 7:150,045,910 |
3×10-16 |
|
|
250 Top |
Hemopexin (trans) |
ZBTB41a, CFHR3c |
rs10754218 1:197,165,014 |
3.2×10-16 |
|
|
251 Top |
IL-23 R (cis) Interleukin-23 receptor |
IL23Rae, C1orf141a |
rs11209026 1:67,705,958 |
3.4×10-16 |
|
|
252 Top |
ARSB (cis) Arylsulfatase B |
ARSBac, BHMTc |
rs672413 5:78,278,229 |
3.6×10-16 |
|
|
253 Top |
MICB (cis) MHC class I polypeptide-related sequence B |
HIST1H4Jabc, ZKSCAN3abc, OR2B2abe, HIST1H2BLab, HIST1H2AIab [37 more]HIST1H4Kab, HIST1H1Bab, HIST1H3Iac, HIST1H4Lab, ZNF165ac, ZSCAN26ac, ZSCAN31ac, ZSCAN23ac, GPX6ab, PGBD1ae, ZSCAN12ae, HIST1H3Ha, HIST1H2AJa, HIST1H2BMa, HIST1H2BNa, HIST1H2AKa, HIST1H2ALa, HIST1H2BOa, HIST1H2AMa, ZSCAN16a, ZKSCAN8a, ZSCAN9a, NKAPLa, RP5-874C20.8a, ZBED9a, GPX5b, PRSS16c, HIST1H3Jc, BTN2A2c, BTN3A2c, BTN3A3c, HIST1H2BKc, ABT1c, ZNF391c, ZFP57c, HLA-Gc, HLA-Cc |
rs33932084 6:28,268,824 |
4.2×10-16 |
|
safety |
254 Top |
Galectin-3 (cis) |
LGALS3abe, FBXO34ace, DLGAP5a, AL158801.1a, ATG14a [3 more]TBPL2a, SOCS4c, KTN1c |
rs35070799 14:55,818,403 |
4.5×10-16 |
|
diagnosis, unspecified application |
255 Top |
PPAC (cis) Low molecular weight phosphotyrosine protein phosphatase |
SH3YL1c |
rs12475664 2:309,097 |
4.6×10-16 replicated |
|
|
256 Top |
C4 (cis) Complement C4 |
ABHD16Aa, XXbac-BPG32J3.20a, LY6G5Cc, OR10C1c |
rs805273 6:31,665,452 |
5.1×10-16 replicated |
|
|
257 Top |
MBL (cis) Mannose-binding protein C |
MBL2a |
rs2506 10:54,525,509 |
5.5×10-16 replicated |
|
diagnosis |
258 Top |
RELT (cis) Tumor necrosis factor receptor superfamily member 19L |
RELTabc, FAM168Aac, ARHGEF17bc, P2RY2b, P2RY6b [1 more]RAB6Ab |
rs7119167 11:73,228,685 |
5.7×10-16 |
|
|
259 Top |
C1s (trans) Complement C1s subcomponent |
CFHac, CFHR2a, CFHR4a, CFHR2a, KCNT2b [4 more]CFHR1c, CFHR3c, JUPd, ZBTB41c |
rs12734260 1:196,865,417 |
5.7×10-16 |
SERPING1 |
|
260 Top |
MICB (cis) MHC class I polypeptide-related sequence B |
MICBac, MUC22c, HCG27c, LST1c, HLA-DRB5c [1 more]HLA-Cc |
rs2534674 6:31,465,103 |
6.9×10-16 |
|
safety |
261 Top |
PLXC1 (cis) Plexin-C1 |
PLXNC1ae, UBE2Nc |
rs7972001 12:94,623,502 |
7.8×10-16 |
|
|
262 Top |
Calcineurin (cis) |
BANK1ac |
rs17266357 4:102,721,809 |
8.7×10-16 |
cyclosporin A |
|
263 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
HLA-Cac, CCHCR1bc, SFTA2b, DDAH2b, PRRC2Ab [15 more]HCG27c, PSORS1C2c, TCF19c, HLA-Bc, POU5F1c, DDR1c, MICBc, PSORS1C1c, C4Bc, MICAc, GPBAR1d, TMEM154d, TRAPPC1d, CD248d, PLOD3d |
rs28367631 6:31,267,936 |
9.8×10-16 replicated |
|
safety |
264 Top |
GOT1 (trans) Aspartate aminotransferase, cytoplasmic |
sentinel not in SNiPA's database
|
rs11292716 7:94,935,199 |
1.2×10-15 |
|
|
264 |
LCMT1 (trans) Leucine carboxyl methyltransferase 1 |
sentinel not in SNiPA's database
|
rs11292716 7:94,935,199 |
5.1×10-15 |
|
|
265 Top |
Kallikrein 7 (cis) Kallikrein-7 |
KLK7abc |
rs2659067 19:51,485,622 |
1.2×10-15 |
|
diagnosis |
266 Top |
FCG2A/B (cis) Low affinity immunoglobulin gamma Fc region receptor II-a/b |
FCGR2Aa, HSPA6a, FCGR3Aa |
rs34436026 1:161,519,440 |
1.5×10-15 |
|
|
267 Top |
Haptoglobin, Mixed Type (cis) Haptoglobin |
PMFBP1abce, DHX38ac, HPRc, DHODHc, HPc [1 more]TXNL4Bc |
rs11645898 16:72,229,532 |
1.5×10-15 |
|
diagnosis, efficacy, unspecified application |
268 Top |
ADAMTS-5 (cis) A disintegrin and metalloproteinase with thrombospondin motifs 5 |
|
rs990529 21:28,346,546 |
1.6×10-15 |
|
|
269 Top |
sTie-1 (trans) Tyrosine-protein kinase receptor Tie-1, soluble |
ABOac, DBHb, ADAMTSL2b, SARDHb, RALGDSb [1 more]MED22c |
rs630510 9:136,149,581 |
1.6×10-15 replicated |
|
|
270 Top |
alpha-1-antichymotrypsin complex (cis) |
SERPINA3a, SERPINA3a |
rs6575449 14:95,097,303 |
1.9×10-15 |
|
unspecified application |
270 |
a1-Antichymotrypsin (cis) Alpha-1-antichymotrypsin |
SERPINA3a, SERPINA3a |
rs6575449 14:95,097,303 |
3.2×10-12 |
|
unspecified application |
271 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
MICAac, MICBc, TNXBc, PSORS1C2c |
rs4418214 6:31,391,401 |
2.2×10-15 |
|
safety |
272 Top |
gp130, soluble (cis) Interleukin-6 receptor subunit beta |
IL6STabce, AC008914.1a, ANKRD55b, DDX4b, SLC38A9b |
rs7730934 5:55,266,512 |
2.6×10-15 replicated |
|
unspecified application |
273 Top |
IL-6 sRa (cis) Interleukin-6 receptor subunit alpha |
HAX1c, UBAP2Lc, S100A4c, IL6Rc |
rs12121180 1:154,282,222 |
2.6×10-15 |
tocilizumab |
efficacy |
274 Top |
ETHE1 (trans) Persulfide dioxygenase ETHE1, mitochondrial |
FETUBa |
rs3733159 3:186,360,409 |
3×10-15 |
|
|
274 |
FETUB (cis) Fetuin-B |
FETUBa |
rs3733159 3:186,360,409 |
1.4×10-9 |
|
|
275 Top |
GPC5 (cis) Glypican-5 |
GPC5ac |
rs7325116 13:92,592,555 |
3.4×10-15 |
|
|
276 Top |
MASP3 (trans) Mannan-binding lectin serine protease 1 |
ZNF385Bc |
rs259842 2:180,738,840 |
3.5×10-15 |
|
|
277 Top |
MICB (cis) MHC class I polypeptide-related sequence B |
C6orf15ac, PSORS1C1ac, CDSNa, FLOT1b, HCG27c [7 more]PSORS1C2c, HLA-Cc, DDR1c, TCF19c, MICBc, POU5F1c, HLA-Bc |
rs3130991 6:31,087,354 |
3.6×10-15 |
|
safety |
278 Top |
TECK (cis) C-C motif chemokine 25 |
ELAVL1a |
rs6603134 19:8,106,521 |
4.1×10-15 replicated |
|
disease progression |
279 Top |
TARC (cis) C-C motif chemokine 17 |
CCL17a |
rs9302690 16:57,442,968 |
4.2×10-15 |
|
|
280 Top |
CNDP1 (cis) Beta-Ala-His dipeptidase |
CNDP1ac |
rs17817077 18:72,209,543 |
4.7×10-15 |
|
|
281 Top |
Haptoglobin, Mixed Type (cis) Haptoglobin |
AC010547.9ac, ZNF19a, MARVELD3c, ZNF23c |
rs8049040 16:71,472,704 |
5.5×10-15 replicated |
|
diagnosis, efficacy, unspecified application |
282 Top |
a1-Antitrypsin (cis) Alpha-1-antitrypsin |
SERPINA1ab, SERPINA9b |
rs2749534 14:94,809,760 |
5.6×10-15 |
|
diagnosis, unspecified application |
283 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
MICAa |
rs17200067 6:31,370,722 |
5.8×10-15 |
|
safety |
284 Top |
LAG-1 (cis) C-C motif chemokine 4-like |
|
rs3213636 17:34,475,131 |
6.1×10-15 |
|
|
285 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
DXOc, LST1c, HLA-Bc, AGERc, MICBc [1 more]PSMB8c |
rs2523710 6:31,450,909 |
6.5×10-15 |
|
safety |
286 Top |
Angiogenin (cis) |
RP11-903H12.5ac, RNASE4ac, ANGac |
rs1888560 14:21,164,245 |
6.7×10-15 replicated |
|
response to therapy |
287 Top |
sLeptin R (cis) Leptin receptor |
LEPRa |
rs4655537 1:66,058,801 |
7.4×10-15 replicated |
recombinant-methionyl human leptin |
prognosis |
288 Top |
Kininogen, HMW (cis) Kininogen-1 |
KNG1a |
rs3856930 3:186,458,322 |
7.6×10-15 |
|
|
289 Top |
Carbonic anhydrase 6 (cis) |
|
rs6665631 1:8,978,514 |
8.1×10-15 |
methazolamide, hydrochlorothiazide, acetazolamide, trichloromethiazide, chlorothiazide, chlorthalidone, benzthiazide, sulfacetamide, topiramate |
|
290 Top |
ARTS1 (cis) Endoplasmic reticulum aminopeptidase 1 |
CASTac, ERAP1c |
rs6556937 5:95,985,282 |
8.4×10-15 |
|
|
291 Top |
Plasminogen (cis) |
PLGab, AGPAT4b |
rs783150 6:161,226,939 |
8.7×10-15 |
tenecteplase, PLAT, tranexamic acid, aprotinin, 6-aminocaproic acid, reteplase |
diagnosis |
292 Top |
HCG (cis) Human Chorionic Gonadotropin |
RUVBL2ac, CGBac, LHBa, CTB-60B18.6a, NUCB1b |
rs753307 19:49,518,484 |
9.4×10-15 |
|
|
293 Top |
Cystatin C (cis) Cystatin-C |
CST3abce, CST9ac, CST5b, CSTL1b, CST8b [4 more]CST11b, GGTLC1b, GZF1b, NAPBc |
rs6036478 20:23,611,359 |
9.6×10-15 |
|
diagnosis, efficacy, prognosis, safety, unspecified application |
294 Top |
RET (cis) Proto-oncogene tyrosine-protein kinase receptor Ret |
CCNYL2b, HNRNPFb, BMS1b, RASGEF1Ab, RETb [1 more]ANKRA2d |
rs2795502 10:43,340,662 |
1×10-14 |
sunitinib, motesanib, cabozantinib, regorafenib, ponatinib, bortezomib/sorafenib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, imatinib/sirolimus, cabozantinib/erlotinib, imatinib/nilotinib/pegintron, imatinib, sorafenib, vandetanib |
efficacy, response to therapy |
295 Top |
MICB (cis) MHC class I polypeptide-related sequence B |
LST1c, PSORS1C2c, HLA-Cc, AIF1c, CCHCR1c [3 more]MICBc, PSORS1C1c, VARS2c |
rs2284178 6:31,432,125 |
1.1×10-14 replicated |
|
safety |
296 Top |
IL-6 sRa (cis) Interleukin-6 receptor subunit alpha |
IL6Rc |
rs9427116 1:154,631,123 |
1.1×10-14 |
tocilizumab |
efficacy |
297 Top |
DERM (cis) Dermatopontin |
DPTabc |
rs494189 1:168,707,757 |
1.1×10-14 replicated |
|
|
298 Top |
Nidogen (trans) Nidogen-1 |
PLXDC2a |
rs9651367 10:20,223,450 |
1.2×10-14 |
|
|
299 Top |
Granulysin (cis) |
GNLYac, ATOH8c |
rs6547631 2:85,909,026 |
1.2×10-14 replicated |
|
|
300 Top |
IL-1Rrp2 (cis) Interleukin-1 receptor-like 2 |
IL1RL2ac |
rs1922291 2:102,828,817 |
1.3×10-14 |
|
|
301 Top |
complement factor H-related 5 (cis) Complement factor H-related protein 5 |
ASPMab, ZBTB41ac, CFHR1bc, CFHR3bc, F13Bae [6 more]CFHR5a, CRB1a, CFHR2b, CFHR2b, CFHb, CFHR4b |
rs6003 1:197,031,021 |
1.5×10-14 |
|
|
302 Top |
ARTS1 (cis) Endoplasmic reticulum aminopeptidase 1 |
LNPEPa, ERAP2c |
rs27303 5:96,374,150 |
1.5×10-14 |
|
|
303 Top |
NPS-PLA2 (cis) Phospholipase A2, membrane associated |
PLA2G5a, MRTO4c, OTUD3c |
rs17354650 1:20,390,322 |
1.7×10-14 replicated |
varespladib methyl, varespladib, indomethacin |
efficacy, prognosis, safety |
304 Top |
CLM6 (trans) CMRF35-like molecule 6 |
POC1B-GALNT4ace, GALNT4ace, POC1Bac, ATP2B1c |
rs722414 12:89,937,437 |
2.3×10-14 replicated |
|
|
305 Top |
Esterase D (cis) S-formylglutathione hydrolase |
HTR2Aa |
rs6561333 13:47,420,312 |
2.7×10-14 |
|
|
306 Top |
RUXF (trans) Small nuclear ribonucleoprotein F |
APOC1a |
rs4420638 19:45,422,946 |
3×10-14 |
|
|
306 |
Apo E2 (cis) Apolipoprotein E (isoform E2) |
APOC1a |
rs4420638 19:45,422,946 |
1.9×10-13 |
|
diagnosis, efficacy, prognosis, unspecified application |
307 Top |
Elafin (cis) |
PI3abce, SEMG2abe, SEMG1ac, SLPIac, WFDC5bc [13 more]DBNDD2bc, PABPC1Lb, SYS1b, STK4b, WFDC11b, WFDC2b, SPINT3b, WFDC9b, WFDC13b, KCNS1c, MATN4c, SYS1-DBNDD2c, WFDC12c |
rs6032067 20:43,864,809 |
3.2×10-14 replicated |
|
|
308 Top |
DLRB1 (trans) Dynein light chain roadblock-type 1 |
TRIM58ac, OR2W3c, OR2T8c |
rs3737276 1:248,024,073 |
3.6×10-14 |
|
|
309 Top |
IL-15 Ra (cis) Interleukin-15 receptor subunit alpha |
IL15RAac, GDI2b |
rs7097780 10:6,010,227 |
3.8×10-14 |
|
prognosis |
310 Top |
CD23 (cis) Low affinity immunoglobulin epsilon Fc receptor |
FCER2ac, CCL25b |
rs11260013 19:7,759,676 |
3.9×10-14 replicated |
|
diagnosis |
311 Top |
I-TAC (cis) C-X-C motif chemokine 11 |
ART3abc, CXCL11abc, CXCL9ab, CXCL10ac, NAAAbc [8 more]NUP54bc, SDAD1b, G3BP2b, PPEF2b, USO1b, SCARB2b, CCDC158b, SLC6A20d |
rs4356932 4:76,955,194 |
4.3×10-14 |
|
|
312 Top |
RGM-C (trans) Hemojuvelin |
NPR2ac, SPAG8ac, TMEM8Bac, HINT2a, FAM221Ba [4 more]GBA2c, MSMPc, HRCT1c, TPM2c |
rs2236293 9:35,841,783 |
4.6×10-14 |
|
|
313 Top |
MSP (cis) Hepatocyte growth factor-like protein |
CDC25Aac, ZNF589ac, CAMPa, UQCRC1b, MAP4b [11 more]FBXW12b, SCAPc, NCKIPSDc, QRICH1c, WDR6c, NME6c, ARIH2OSc, AMTc, KLHDC8Bc, TMA7c, NICN1c |
rs6442112 3:48,316,034 |
4.7×10-14 |
|
|
314 Top |
C7 (cis) Complement component C7 |
PTGER4c |
rs7713972 5:40,552,474 |
5.2×10-14 |
|
|
315 Top |
IGF-II receptor (cis) Cation-independent mannose-6-phosphate receptor |
SLC22A1ac, MAS1c |
rs9295123 6:160,570,114 |
5.3×10-14 replicated |
|
|
316 Top |
MMP-7 (cis) Matrilysin |
MMP7ac |
rs11568819 11:102,401,633 |
5.8×10-14 |
marimastat |
diagnosis |
317 Top |
PCSK7 (cis) Proprotein convertase subtilisin/kexin type 7 |
RNF214ac, PCSK7ac, BACE1ac, TAGLNc, SIDT2c |
rs7083 11:117,156,552 |
6.3×10-14 |
|
unspecified application |
318 Top |
ARSB (cis) Arylsulfatase B |
ARSBac |
rs6865582 5:78,201,833 |
7.2×10-14 |
|
|
319 Top |
Haptoglobin, Mixed Type (cis) Haptoglobin |
|
rs8044476 16:72,800,567 |
7.7×10-14 |
|
diagnosis, efficacy, unspecified application |
320 Top |
a1-Antitrypsin (cis) Alpha-1-antitrypsin |
SERPINA6a, SERPINA1c |
rs4905179 14:94,795,492 |
7.7×10-14 |
|
diagnosis, unspecified application |
321 Top |
annexin II (cis) Annexin A2 |
|
rs338419 15:60,517,276 |
7.7×10-14 |
|
diagnosis, unspecified application |
322 Top |
C1-Esterase Inhibitor (cis) Plasma protease C1 inhibitor |
SLC43A1abc, SMTNL1ac, YPEL4bc, ZDHHC5bc, UBE2L6a [8 more]RP11-872D17.8b, PRG2b, CLP1b, RTN4RL2b, SLC43A3b, BTBD18c, TIMM10c, SERPING1c |
rs2729354 11:57,355,970 |
8×10-14 |
|
|
323 Top |
GPNMB (cis) Transmembrane glycoprotein NMB |
GPNMBac, KLHL7c, NUPL2c |
rs5850 7:23,314,547 |
8.1×10-14 |
|
unspecified application |
324 Top |
Angiogenin (cis) |
RP11-903H12.5c, RNASE6c, ANGc |
rs11624221 14:21,128,050 |
8.6×10-14 |
|
response to therapy |
325 Top |
sLeptin R (cis) Leptin receptor |
LEPRac, DNAJC6b, AK4b, LEPROTc |
rs17412403 1:65,942,266 |
8.7×10-14 replicated |
recombinant-methionyl human leptin |
prognosis |
326 Top |
complement factor H-related 5 (cis) Complement factor H-related protein 5 |
CFHa |
rs35908703 1:196,692,940 |
8.8×10-14 |
|
|
326 |
Factor H (cis) Complement factor H |
CFHa |
rs35908703 1:196,692,940 |
5.7×10-12 |
|
unspecified application |
327 Top |
TIMP-3 (cis) Metalloproteinase inhibitor 3 |
SYN3a |
rs5754266 22:33,172,005 |
1.2×10-13 |
|
diagnosis, prognosis, unspecified application |
328 Top |
MP2K2 (trans) Dual specificity mitogen-activated protein kinase kinase 2 |
PCID2ac, CUL4Aa |
rs9577481 13:113,860,900 |
1.2×10-13 |
selumetinib, trametinib, dabrafenib/trametinib |
|
329 Top |
PDGF Rb (cis) Platelet-derived growth factor receptor beta |
CSF1Rac, PDGFRBc |
rs11746309 5:149,479,647 |
1.2×10-13 |
nilotinib, dasatinib, sunitinib, pazopanib, axitinib, tivozanib, tandutinib, nintedanib, regorafenib, bortezomib/sorafenib, lapatinib/pazopanib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, imatinib/sirolimus, imatinib, sorafenib, becaplermin |
prognosis, response to therapy, unspecified application |
330 Top |
MICB (cis) MHC class I polypeptide-related sequence B |
BTN3A3abc, BTN1A1abe, HMGN4ab, ABT1ab, BTN3A2bc [17 more]HIST1H2BDbc, BTN2A1ae, ZNF322a, BTN3A1b, HIST1H4Db, HIST1H2ADb, HIST1H4Eb, HIST1H3Fb, HIST1H4Cb, HIST1H2BFb, BTN2A2c, HIST1H4Hc, SCGNc, TRIM38c, ZNF391c, PRSS16c, HIST1H4Jc |
rs35555795 6:26,509,382 |
1.3×10-13 |
|
safety |
331 Top |
FCN2 (cis) Ficolin-2 |
FCN1a |
rs2989736 9:137,797,175 |
1.3×10-13 |
|
|
332 Top |
NKG2D (cis) NKG2-D type II integral membrane protein |
KLRK1abce, KLRC3abc, KLRC2abc, KLRC4-KLRK1ace, KLRC1ac [7 more]KLRD1bc, KLRC4a, RP11-277P12.6a, CLEC1Ab, GABARAPL1c, YBX3c, TAS2R10c |
rs2255336 12:10,532,326 |
1.3×10-13 |
|
|
333 Top |
BCAR3 (trans) Breast cancer anti-estrogen resistance protein 3 |
TMEM97c, TMEM199c, SARM1c |
rs9901901 17:26,610,513 |
1.3×10-13 |
|
|
333 |
OCAD1 (trans) OCIA domain-containing protein 1 |
TMEM97c, TMEM199c, SARM1c |
rs9901901 17:26,610,513 |
3.4×10-13 |
|
|
333 |
Macrophage scavenger receptor (trans) Macrophage scavenger receptor types I and II |
TMEM97c, TMEM199c, SARM1c |
rs9901901 17:26,610,513 |
9.3×10-12 |
|
|
333 |
ABL2 (trans) Abelson tyrosine-protein kinase 2 |
TMEM97c, TMEM199c, SARM1c |
rs9901901 17:26,610,513 |
2.2×10-10 |
|
|
333 |
TYK2 (trans) Non-receptor tyrosine-protein kinase TYK2 |
TMEM97c, TMEM199c, SARM1c |
rs9901901 17:26,610,513 |
5.8×10-9 |
|
|
333 |
DRAK2 (trans) Serine/threonine-protein kinase 17B |
TMEM97c, TMEM199c, SARM1c |
rs9901901 17:26,610,513 |
8.7×10-9 |
|
|
334 Top |
TXD12 (trans) Thioredoxin domain-containing protein 12 |
sentinel not in SNiPA's database
|
rs35365539 3:49,794,348 |
1.4×10-13 |
|
|
335 Top |
CATZ (trans) Cathepsin Z |
GNPTABa, CCDC53b, CHPT1c, DRAM1c |
rs10860794 12:102,217,720 |
1.4×10-13 |
|
|
335 |
Cathepsin A (trans) Lysosomal protective protein |
GNPTABa, CCDC53b, CHPT1c, DRAM1c |
rs10860794 12:102,217,720 |
2.2×10-11 |
|
|
336 Top |
TIMP-3 (cis) Metalloproteinase inhibitor 3 |
SYN3a |
rs5754249 22:33,147,526 |
1.7×10-13 |
|
diagnosis, prognosis, unspecified application |
337 Top |
ASAHL (cis) N-acylethanolamine-hydrolyzing acid amidase |
NAAAac, ART3b, CXCL9b, SDAD1b, PPEF2c [1 more]CDKL2c |
rs1513890 4:76,835,364 |
1.8×10-13 |
|
|
338 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
MUC22a, HCG27c, PSORS1C2c, MICAc, CCHCR1c [2 more]VARS2c, PSORS1C1c |
rs11753208 6:31,005,432 |
2×10-13 |
|
safety |
339 Top |
PDGF Rb (cis) Platelet-derived growth factor receptor beta |
PDGFRBa |
rs17708574 5:149,521,238 |
2.2×10-13 replicated |
nilotinib, dasatinib, sunitinib, pazopanib, axitinib, tivozanib, tandutinib, nintedanib, regorafenib, bortezomib/sorafenib, lapatinib/pazopanib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, imatinib/sirolimus, imatinib, sorafenib, becaplermin |
prognosis, response to therapy, unspecified application |
340 Top |
GPC5 (cis) Glypican-5 |
GPC5ac |
rs2147190 13:92,058,888 |
2.3×10-13 |
|
|
341 Top |
IL-18 Ra (cis) Interleukin-18 receptor 1 |
sentinel not in SNiPA's database
|
rs6725806 2:103,216,172 |
2.4×10-13 |
|
|
342 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
TRIM31abce, TRIM40a, HLA-Fc, HLA-DQA1c, HLA-DQB1c [10 more]HLA-Cc, PPP1R11c, BTN3A3c, BTN3A2c, HLA-Gc, ZFP57c, IER3c, HIST1H3Ic, HLA-Ac, PPP1R18c |
rs2523987 6:30,079,993 |
2.4×10-13 |
|
safety |
343 Top |
DKK3 (cis) Dickkopf-related protein 3 |
MICALCLb, DKK3c, USP47c |
rs11022119 11:12,050,652 |
2.8×10-13 |
|
|
344 Top |
ASAH2 (cis) Neutral ceramidase |
|
rs2338747 10:48,005,276 |
3.3×10-13 |
|
|
345 Top |
Plasminogen (cis) |
AGPAT4b |
rs2565722 6:161,235,142 |
3.9×10-13 |
tenecteplase, PLAT, tranexamic acid, aprotinin, 6-aminocaproic acid, reteplase |
diagnosis |
346 Top |
MAPK2 (cis) MAP kinase-activated protein kinase 2 |
IL19bc, MAPKAPK2a, IKBKEb |
rs6669284 1:206,890,435 |
3.9×10-13 |
|
|
347 Top |
Cripto (cis) Teratocarcinoma-derived growth factor 1 |
LRRC2ac, TDGF1c |
rs939421 3:46,576,081 |
4×10-13 |
|
diagnosis |
348 Top |
Trypsin 2 (trans) Trypsin-2 |
TRBV30ac, TRBV3-1b, TRBJ2-2b, TRBV27b, TRBV4-1b [17 more]TRBJ2-2Pb, TRBJ2-1b, TRPV5b, TRBV5-1b, TRBV10-2b, TRBV7-6b, TRBV24-1b, TRBV4-2b, TRBV29-1b, TRBJ2-5b, TRBJ2-4b, TRBV7-7b, TRBJ2-7b, TRBJ2-6b, TRBV7-1b, TRBV5-3b, EPHB6c |
rs3134906 7:142,505,154 |
4.2×10-13 |
|
|
349 Top |
DC-SIGN (cis) CD209 antigen |
CLEC4Gac, C19orf45b, CCL25b, TGFBR3Lc, XAB2c [3 more]FCER2c, MCEMP1c, CD209c |
rs8106657 19:7,788,091 |
4.2×10-13 |
|
|
350 Top |
MMP-8 (trans) Neutrophil collagenase |
C6orf48ab, HSPA1Lae, LSM2a, HSPA1Aa, NEU1a [3 more]SLC44A4a, CFBb, AGERb |
rs2227955 6:31,778,077 |
4.2×10-13 |
marimastat |
efficacy |
350 |
C34 gp41 HIV Fragment (trans) gp41 C34 peptide, HIV |
C6orf48ab, HSPA1Lae, LSM2a, HSPA1Aa, NEU1a [3 more]SLC44A4a, CFBb, AGERb |
rs2227955 6:31,778,077 |
3.8×10-9 |
|
|
351 Top |
sICAM-5 (cis) Intercellular adhesion molecule 5 |
TYK2bc, PDE4Aae, ZGLP1b, PPAN-P2RY11b, KRI1b [6 more]PPANb, P2RY11b, S1PR5c, KEAP1c, ICAM4c, SLC44A2c |
rs1051738 19:10,577,843 |
4.6×10-13 |
|
|
352 Top |
6Ckine (trans) C-C motif chemokine 21 |
DNAJC13abc, ACAD11abe, NPHP3ac, NPHP3-ACAD11a, ACKR4a [1 more]UBA5a |
rs17412738 3:132,257,419 |
5.3×10-13 replicated |
|
disease progression |
353 Top |
IMDH1 (trans) Inosine-5'-monophosphate dehydrogenase 1 |
ARHGEF3ab, CCDC66b |
rs1354034 3:56,849,749 |
5.4×10-13 |
thioguanine, VX-944, pegintron/ribavirin, PEG-interferon alfa-2a/ribavirin, nitazoxanide/peginterferon alfa-2a/ribavirin, interferon alfa-2b/ribavirin, mycophenolate mofetil, mycophenolic acid, ribavirin |
|
353 |
DLRB1 (trans) Dynein light chain roadblock-type 1 |
ARHGEF3ab, CCDC66b |
rs1354034 3:56,849,749 |
6.1×10-11 |
|
|
353 |
AMPM2 (trans) Methionine aminopeptidase 2 |
ARHGEF3ab, CCDC66b |
rs1354034 3:56,849,749 |
1.2×10-9 |
nitroxoline, beloranib, PPI-2458 |
unspecified application |
354 Top |
sE-Selectin (trans) E-Selectin |
ABOac, SURF6c |
rs8176720 9:136,132,873 |
5.8×10-13 |
|
diagnosis, disease progression, efficacy, unspecified application |
354 |
ATS13 (cis) A disintegrin and metalloproteinase with thrombospondin motifs 13 |
ABOac, SURF6c |
rs8176720 9:136,132,873 |
6.4×10-10 |
|
|
354 |
IR (trans) Insulin receptor |
ABOac, SURF6c |
rs8176720 9:136,132,873 |
7.4×10-10 replicated |
insulin detemir, INS, canakinumab/INS, insulin aspart/insulin detemir, ceritinib, insulin glargine/insulin lispro, insulin aspart, insulin glulisine, insulin lispro, insulin glargine, protamine zinc insulin |
prognosis |
355 Top |
GPVI (cis) Platelet glycoprotein VI |
RDH13a, KIR3DL2b, KIR3DL1b, LILRA1b, KIR2DL3b [9 more]KIR2DL1b, LILRB4b, KIR2DL4b, LILRA2b, FCARb, NLRP2b, LILRB1b, KIR3DL3b, GP6c |
rs11672111 19:55,565,634 |
6.8×10-13 |
|
|
356 Top |
MP2K4 (trans) Dual specificity mitogen-activated protein kinase kinase 4 |
sentinel not in SNiPA's database
|
rs10127775 1:230,295,789 |
6.9×10-13 |
|
|
357 Top |
Apo B (cis) Apolipoprotein B |
APOBae |
rs520354 2:21,259,612 |
6.9×10-13 |
mipomersen |
diagnosis, efficacy |
358 Top |
IGF-II receptor (cis) Cation-independent mannose-6-phosphate receptor |
IGF2Rac, MAS1a, TCP1b, SOD2b, SLC22A1c [1 more]WTAPc |
rs12202350 6:160,379,096 |
7.1×10-13 |
|
|
359 Top |
PARC (cis) C-C motif chemokine 18 |
|
rs35871176 17:34,375,832 |
7.3×10-13 |
|
efficacy, safety |
360 Top |
VEGF sR3 (trans) Vascular endothelial growth factor receptor 3 |
DCBLD2c, ST3GAL6c |
rs13318932 3:98,396,350 |
8×10-13 |
sunitinib, pazopanib, axitinib, CEP 7055, tivozanib, motesanib, telatinib, cabozantinib, nintedanib, regorafenib, bortezomib/sorafenib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, cabozantinib/erlotinib, sorafenib, vandetanib |
diagnosis, disease progression, efficacy, prognosis |
361 Top |
ASAH2 (cis) Neutral ceramidase |
|
rs12411860 10:52,038,032 |
8×10-13 |
|
|
362 Top |
MAPKAPK3 (trans) MAP kinase-activated protein kinase 3 |
LCP1a |
rs9534338 13:46,707,137 |
8×10-13 |
|
unspecified application |
363 Top |
GPNMB (cis) Transmembrane glycoprotein NMB |
GPNMBab, KLHL7a, TOMM7b |
rs858267 7:23,210,129 |
8.4×10-13 |
|
unspecified application |
364 Top |
CNTN2 (cis) Contactin-2 |
NFASCab, LRRN2b, TMCC2b |
rs3795559 1:204,989,911 |
8.4×10-13 replicated |
|
|
365 Top |
C8 (cis) Complement component C8 |
C8Bae |
rs1013579 1:57,422,484 |
9.3×10-13 |
|
|
365 |
NXPH1 (trans) Neurexophilin-1 |
C8Bae |
rs1013579 1:57,422,484 |
1×10-10 |
|
|
366 Top |
MIP-5 (cis) C-C motif chemokine 15 |
CCL14a, CCL15-CCL14a, CCL15a, CCL23a |
rs2056492 17:34,318,565 |
9.9×10-13 |
|
|
367 Top |
HRG (cis) Histidine-rich glycoprotein |
KNG1ac |
rs1403694 3:186,439,998 |
1.2×10-12 |
|
|
368 Top |
TFF3 (trans) Trefoil factor 3 |
NFKBIL1a, SKIV2Lc, TCF19c, PSORS1C2c |
rs2524277 6:31,407,579 |
1.2×10-12 |
|
diagnosis, unspecified application |
369 Top |
LD78-beta (cis) C-C motif chemokine 3-like 1 |
CCL18a |
rs16971895 17:34,386,399 |
1.2×10-12 |
|
|
370 Top |
KI2L4 (cis) Killer cell immunoglobulin-like receptor 2DL4 |
FCARa |
rs7259090 19:55,392,646 |
1.3×10-12 |
|
|
371 Top |
ATS13 (cis) A disintegrin and metalloproteinase with thrombospondin motifs 13 |
SURF6a, MED22a |
rs4962130 9:136,195,607 |
1.3×10-12 |
|
|
372 Top |
C4 (cis) Complement C4 |
HLA-DRAabc, CYP21A2bc, C4Bbc, PSMB9bc, HLA-DOBbc [24 more]HLA-DRB5bc, HLA-DQB2b, FKBPLb, PRRT1b, BTNL2b, HLA-DQA1b, HLA-DQB1b, TAP1b, PBX2b, C4Ac, RNF5c, NOTCH4c, HLA-DRB1c, HLA-DMAc, HLA-DPB1c, MICBc, C6orf25c, LY6G6Cc, HLA-DQA2c, XXbac-BPG246D15.9c, LIMS1d, HLA-DMBc, LST1c, APOMc |
rs2239805 6:32,411,376 |
1.4×10-12 |
|
|
373 Top |
HCC-1 (cis) C-C motif chemokine 14 |
CCL14c, CCL15-CCL14c, CCL23c |
rs854658 17:34,352,666 |
1.5×10-12 |
|
|
374 Top |
ECM1 (cis) Extracellular matrix protein 1 |
TARS2abc, PRPF3ab, RPRD2ac, ECM1ac, CTSSbc [8 more]MRPS21ae, AC242988.1a, ADAMTSL4b, MCL1b, ANP32Eb, VPS45b, C1orf54c, HORMAD1c |
rs12724450 1:150,480,571 |
1.6×10-12 |
|
diagnosis |
375 Top |
BST1 (cis) ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 |
CD38ac, FBXL5c |
rs4473651 4:15,770,911 |
1.6×10-12 |
|
|
376 Top |
MSP (cis) Hepatocyte growth factor-like protein |
MAPKAPK3ac, DOCK3a, HYAL3c, NAT6c, WDR6c [3 more]C3orf62c, USP4c, RPL29c |
rs9869826 3:50,998,816 |
1.8×10-12 |
|
|
377 Top |
TARC (trans) C-C motif chemokine 17 |
PLCL2abc |
rs983545 3:16,959,652 |
2.3×10-12 |
|
|
378 Top |
Plasminogen (cis) |
MAP3K4ac |
rs3798911 6:161,465,297 |
2.5×10-12 |
tenecteplase, PLAT, tranexamic acid, aprotinin, 6-aminocaproic acid, reteplase |
diagnosis |
379 Top |
C4b (cis) Complement C4b |
TNXBab, ATF6Ba, FKBPLa, CFBb, PRRC2Ab [5 more]DDAH2b, SKIV2Lc, LST1c, EHMT2c, ABCF1c |
rs204888 6:32,089,142 |
2.5×10-12 |
|
|
380 Top |
FN1.3 (cis) Fibronectin Fragment 3 |
sentinel not in SNiPA's database
|
rs35233997 2:216,238,970 |
2.5×10-12 |
ocriplasmin |
diagnosis, efficacy, prognosis, unspecified application |
381 Top |
SIG14 (cis) Sialic acid-binding Ig-like lectin 14 |
|
rs17660992 19:52,163,948 |
2.6×10-12 replicated |
|
|
382 Top |
BST1 (cis) ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 |
BST1a |
rs1110258 4:15,742,716 |
2.7×10-12 |
|
|
383 Top |
ADAMTS-5 (cis) A disintegrin and metalloproteinase with thrombospondin motifs 5 |
ADAMTS1a, GABPAc |
rs229100 21:28,223,092 |
2.9×10-12 |
|
|
384 Top |
Afamin (cis) |
AFMabe, RASSF6ac, AFPb |
rs41265665 4:74,361,142 |
3×10-12 replicated |
|
|
385 Top |
Siglec-9 (cis) Sialic acid-binding Ig-like lectin 9 |
KLK14a |
rs3745542 19:51,587,643 |
3.1×10-12 |
|
|
386 Top |
IL-18 Ra (cis) Interleukin-18 receptor 1 |
IL1RL2a, IL1RL1c, IL18R1c |
rs9646944 2:102,865,875 |
3.2×10-12 |
|
|
387 Top |
granzyme A (trans) Granzyme A |
HLA-Cac, HLA-Bac, TCF19c, VARS2c, HCG27c [16 more]PSORS1C2c, CCHCR1c, DDX39Bc, PSORS1C1c, ATP6V1G2c, MICAc, MICBc, TSSC4d, TMEM154d, FLOT1c, XRCC6d, CD248d, CSF3Rd, BAG6c, C4Bc, TNXBc |
rs2853928 6:31,257,511 |
3.4×10-12 |
|
|
388 Top |
EPHB2 (cis) Ephrin type-B receptor 2 |
EPHB2ac, C1QAb, C1QBb |
rs6687487 1:23,061,551 |
3.5×10-12 |
|
unspecified application |
389 Top |
ASAHL (trans) N-acylethanolamine-hydrolyzing acid amidase |
CHPT1ac, MYBPC1a, GNPTABc |
rs2559856 12:102,089,561 |
3.6×10-12 |
|
|
390 Top |
PDE5A (cis) cGMP-specific 3',5'-cyclic phosphodiesterase |
C4orf3ac, FABP2ac, PDE5Ac, USP53c |
rs4834770 4:120,241,849 |
3.6×10-12 |
dyphylline, nitroglycerin, udenafil, avanafil, aspirin/dipyridamole/telmisartan, aminophylline, sildenafil, dipyridamole, aspirin/dipyridamole, vardenafil, tolbutamide, tadalafil, theophylline, pentoxifylline |
diagnosis |
391 Top |
Coagulation Factor XI (cis) |
CYP4V2ac, KLKB1ac, F11b, FAT1b |
rs6842047 4:187,133,576 |
3.7×10-12 |
|
|
392 Top |
Siglec-9 (cis) Sialic acid-binding Ig-like lectin 9 |
CTU1a, SHANK1b, SIGLEC9c |
rs17801525 19:51,615,155 |
3.9×10-12 replicated |
|
|
393 Top |
C7 (cis) Complement component C7 |
C7abe, C6c |
rs10473230 5:40,982,031 |
3.9×10-12 |
|
|
394 Top |
HRG (cis) Histidine-rich glycoprotein |
|
rs1846899 3:186,472,816 |
4×10-12 |
|
|
395 Top |
MIP-5 (cis) C-C motif chemokine 15 |
CCL15-CCL14a, CCL15a |
rs2075746 17:34,325,532 |
4.3×10-12 replicated |
|
|
396 Top |
MFGM (cis) Lactadherin |
MFGE8abc, HAPLN3ac |
rs3743392 15:89,445,651 |
4.8×10-12 |
|
|
397 Top |
IL-17E (trans) Interleukin-25 |
POU2F3a |
rs7121784 11:120,159,052 |
5.3×10-12 |
|
|
398 Top |
IL-1Rrp2 (cis) Interleukin-1 receptor-like 2 |
IL1R1abe, IL1RL2ab, IL1RL1b |
rs4851551 2:102,800,230 |
5.8×10-12 |
|
|
399 Top |
CYTD (cis) Cystatin-D |
CST2ac, CST1c |
rs4585101 20:23,847,254 |
5.9×10-12 |
|
|
400 Top |
Carbonic anhydrase 6 (cis) |
CA6abe, REREb |
rs3765967 1:9,011,627 |
6.1×10-12 replicated |
methazolamide, hydrochlorothiazide, acetazolamide, trichloromethiazide, chlorothiazide, chlorthalidone, benzthiazide, sulfacetamide, topiramate |
|
401 Top |
PIGR (cis) Polymeric immunoglobulin receptor |
sentinel not in SNiPA's database
|
rs35400166 1:207,064,011 |
6.3×10-12 replicated |
|
unspecified application |
402 Top |
SPARCL1 (cis) SPARC-like protein 1 |
SPARCL1c, HSD17B13c |
rs1462372 4:88,478,750 |
6.3×10-12 replicated |
|
disease progression |
403 Top |
HGFA (cis) Hepatocyte growth factor activator |
RGS12ab, SH3BP2b, HGFACb, ADRA2Cb, ADD1b [2 more]LRPAP1b, MFSD10b |
rs3135063 4:3,287,052 |
6.7×10-12 |
|
|
404 Top |
GOT1 (trans) Aspartate aminotransferase, cytoplasmic |
PON1ac, ASB4c, PON2c |
rs757158 7:94,955,528 |
7×10-12 |
|
|
405 Top |
CYTF (cis) Cystatin-F |
CST7b, PYGBb, ACSS1b, ABHD12c |
rs6050091 20:24,873,553 |
7.5×10-12 |
|
|
406 Top |
ESAM (cis) Endothelial cell-selective adhesion molecule |
VSIG2ac, NRGNa, ESAMa, MSANTD2c |
rs11219769 11:124,620,147 |
7.8×10-12 replicated |
|
|
407 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
MICBa, MCCD1a, ATP6V1G2a, ATP6V1G2-DDX39Ba, NFKBIL1a [2 more]LST1a, NCR3a |
rs17200698 6:31,483,700 |
1.1×10-11 |
|
safety |
408 Top |
IL-1 R4 (cis) Interleukin-1 receptor-like 1 |
IL18R1abc, IL1RL1abc, IL18RAPa, IL1R1b |
rs3771167 2:102,986,188 |
1.1×10-11 |
|
|
409 Top |
IL-1 R4 (cis) Interleukin-1 receptor-like 1 |
IL1R1a |
rs3917254 2:102,776,518 |
1.2×10-11 |
|
|
410 Top |
MAPKAPK3 (trans) MAP kinase-activated protein kinase 3 |
CPB2a, ZC3H13c |
rs17844003 13:46,670,347 |
1.2×10-11 |
|
unspecified application |
411 Top |
MAPKAPK3 (trans) MAP kinase-activated protein kinase 3 |
ZC3H13a |
rs12585823 13:46,536,291 |
1.2×10-11 |
|
unspecified application |
412 Top |
C1-Esterase Inhibitor (cis) Plasma protease C1 inhibitor |
OR9Q1a, OR9I1a, OR5B21b, LPXNb, ZDHHC5b [2 more]MED19c, TIMM10c |
rs12788387 11:57,893,347 |
1.5×10-11 |
|
|
413 Top |
Coagulation Factor V (cis) |
F5ae |
rs9332653 1:169,490,772 |
1.6×10-11 replicated |
drotrecogin alfa, antithrombin alfa |
diagnosis |
413 |
CAMK1 (trans) Calcium/calmodulin-dependent protein kinase type 1 |
F5ae |
rs9332653 1:169,490,772 |
1.9×10-11 replicated |
|
|
414 Top |
RET (cis) Proto-oncogene tyrosine-protein kinase receptor Ret |
RETbc, CCNYL2b |
rs2506028 10:43,444,534 |
1.8×10-11 |
sunitinib, motesanib, cabozantinib, regorafenib, ponatinib, bortezomib/sorafenib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, imatinib/sirolimus, cabozantinib/erlotinib, imatinib/nilotinib/pegintron, imatinib, sorafenib, vandetanib |
efficacy, response to therapy |
415 Top |
IL-1 R4 (cis) Interleukin-1 receptor-like 1 |
SLC9A4ab, TMEM182b, IL18R1c, IL18RAPc |
rs4851016 2:103,120,400 |
1.8×10-11 replicated |
|
|
416 Top |
Caspase-3 (cis) |
PRIMPOLabce, CASP3ac, ACSL1b, IRF2b, CENPUc |
rs870825 4:185,588,045 |
1.8×10-11 |
emricasan |
diagnosis, disease progression, efficacy, unspecified application |
417 Top |
EDAR (trans) Tumor necrosis factor receptor superfamily member EDAR |
ZFPM2a, CXCL5d |
rs16873418 8:106,592,145 |
1.9×10-11 replicated |
|
|
417 |
Integrin a1b1 (trans) Integrin alpha-I: beta-1 complex |
ZFPM2a, CXCL5d |
rs16873418 8:106,592,145 |
1.4×10-9 |
|
|
418 Top |
IL-16 (cis) Interleukin-16 |
IL16a |
rs11072996 15:81,529,410 |
2.1×10-11 |
|
|
419 Top |
TSG-6 (cis) Tumor necrosis factor-inducible gene 6 protein |
TNFAIP6abe, RBM43c, NMIc |
rs1046668 2:152,226,570 |
2.1×10-11 |
|
unspecified application |
420 Top |
Angiotensinogen (cis) |
CAPN9a |
rs2493151 1:230,878,561 |
2.2×10-11 |
|
efficacy |
421 Top |
IL-17 sR (cis) Interleukin-17 receptor A |
CECR5a, CECR6c |
rs5994176 22:17,618,164 |
2.3×10-11 |
|
|
422 Top |
NXPH1 (trans) Neurexophilin-1 |
C8Ba |
rs668555 1:57,426,454 |
2.4×10-11 |
|
|
423 Top |
MICA (cis) MHC class I polypeptide-related sequence A |
TRIM15abce, TRIM10abc, TRIM40ab, TRIM31a, TRIM26a [4 more]TRIM39b, PPP1R11c, MICAc, HLA-Gc |
rs9368624 6:30,135,977 |
2.5×10-11 |
|
safety |
424 Top |
sLeptin R (cis) Leptin receptor |
LEPRac, LEPROTc |
rs7535099 1:66,050,997 |
3.1×10-11 |
recombinant-methionyl human leptin |
prognosis |
425 Top |
Angiostatin (cis) |
LPAa |
rs41265930 6:160,964,135 |
3.4×10-11 |
tenecteplase, PLAT, tranexamic acid, aprotinin, 6-aminocaproic acid, reteplase |
diagnosis |
426 Top |
MMP-8 (trans) Neutrophil collagenase |
|
rs7896471 10:101,788,308 |
3.4×10-11 |
marimastat |
efficacy |
427 Top |
LAG-1 (trans) C-C motif chemokine 4-like |
CCR3abc, CCRL2abe, CCR2ab, CCR5ab, LTFab [9 more]LRRC2bc, ALS2CLb, XCR1b, CCR1b, CCR9b, CXCR6b, LZTFL1b, PRSS50b, LIMD1c |
rs6808835 3:46,449,864 |
3.5×10-11 |
|
|
428 Top |
Siglec-6 (cis) Sialic acid-binding Ig-like lectin 6 |
SIGLEC6ae, SIGLEC12c |
rs35931837 19:52,033,158 |
3.6×10-11 |
|
|
429 Top |
VEGF sR3 (trans) Vascular endothelial growth factor receptor 3 |
ST3GAL6a |
rs3213958 3:98,487,206 |
3.7×10-11 |
sunitinib, pazopanib, axitinib, CEP 7055, tivozanib, motesanib, telatinib, cabozantinib, nintedanib, regorafenib, bortezomib/sorafenib, dexamethasone/lenalidomide/sorafenib, bevacizumab/sorafenib, cabozantinib/erlotinib, sorafenib, vandetanib |
diagnosis, disease progression, efficacy, prognosis |
430 Top |
PPAC (cis) Low molecular weight phosphotyrosine protein phosphatase |
SH3YL1abc, ACP1a, FAM150Ba, TMEM18b |
rs300703 2:239,416 |
3.8×10-11 |
|
|
431 Top |
TIMP-3 (cis) Metalloproteinase inhibitor 3 |
SYN3a |
rs3788504 22:33,160,397 |
3.9×10-11 |
|
diagnosis, prognosis, unspecified application |
432 Top |
CNTN2 (cis) Contactin-2 |
CNTN2abc, RBBP5ac, TMEM81a, DSTYKc, TMCC2c |
rs41264869 1:205,030,862 |
4×10-11 replicated |
|
|
433 Top |
TARC (trans) C-C motif chemokine 17 |
ACKR2ae, KRBOX1a, CYP8B1a, RP11-136C24.3a |
rs2228467 3:42,906,116 |
4.2×10-11 |
|
|
434 Top |
CNTN2 (cis) Contactin-2 |
NFASCa |
rs2246662 1:204,943,947 |
4.5×10-11 |
|
|
435 Top |
DERM (cis) Dermatopontin |
DPTac, TBX19b |
rs530022 1:168,675,971 |
4.5×10-11 replicated |
|
|
436 Top |
annexin I (cis) Annexin A1 |
ANXA1abc |
rs4745216 9:75,744,157 |
5.2×10-11 |
hydrocortisone, hydrocortisone/prednisone, hydrocortisone/mitoxantrone |
diagnosis, prognosis, unspecified application |
437 Top |
EMR2 (cis) EGF-like module-containing mucin-like hormone receptor-like 2 |
ADGRE5a |
rs7260110 19:14,501,544 |
5.2×10-11 |
|
|
438 Top |
CAMK1 (trans) Calcium/calmodulin-dependent protein kinase type 1 |
|
rs12241254 10:101,329,158 |
5.3×10-11 |
|
|
439 Top |
IL-1 R AcP (cis) Interleukin-1 Receptor accessory protein |
IL1RAPa |
rs9811674 3:190,287,162 |
5.3×10-11 |
|
|
440 Top |
GFRa-2 (cis) GDNF family receptor alpha-2 |
NPM2b, FGF17b, FAM160B2b, GFRA2c |
rs10503709 8:21,474,049 |
5.4×10-11 |
|
|
441 Top |
AK1A1 (cis) Alcohol dehydrogenase [NADP(+)] |
MAST2abc, TESK2ab, PRDX1ac, MMACHCac, GPBP1L1ab [9 more]TMEM69ac, PIK3R3bc, CCDC163Pa, NASPa, CCDC17a, IPPa, AKR1A1b, HPDLb, TOE1b |
rs6662572 1:46,146,812 |
5.8×10-11 |
|
|
442 Top |
sTie-1 (trans) Tyrosine-protein kinase receptor Tie-1, soluble |
ABOac, SURF1c, SLC2A6c, GBGT1c |
rs7857390 9:136,128,546 |
5.8×10-11 replicated |
|
|
443 Top |
Cripto (cis) Teratocarcinoma-derived growth factor 1 |
TDGF1ac, PRSS50b, CCR2b, LRRC2b, CCR3b [4 more]PRSS46c, TREX1c, ATRIPc, TREX1c |
rs7610301 3:46,646,028 |
5.9×10-11 replicated |
|
diagnosis |
444 Top |
SAP (cis) Serum amyloid P-component |
APCSab, OR10J1b, OR10J5b, SLAMF8b, CADM3b [3 more]IGSF8b, CXCL10d, CXCL11d |
rs12079353 1:159,554,607 |
6.3×10-11 |
|
unspecified application |
445 Top |
IL-17B R (cis) interleukin-17 receptor B |
CACNA1Da, DCP1Ab, CHDHc, IL17RBc |
rs4453827 3:53,750,084 |
6.4×10-11 |
|
|
446 Top |
ART (cis) Agouti-related protein |
SMPD3a, TRADDc, DUS2c, ATP6V0D1c |
rs8051517 16:68,428,089 |
6.9×10-11 |
|
unspecified application |
447 Top |
C4 (cis) Complement C4 |
MUC22ac, VARS2bc, MICBbc, FLOT1bc, MUC21a [11 more]CDSNb, ATAT1b, GNL1b, PRR3b, PPP1R10b, HCG27b, DDR1b, TRIM31c, CCHCR1c, HLA-Cc, C4Ac |
rs1634718 6:30,972,865 |
7.4×10-11 |
|
|
448 Top |
TLR4:MD-2 complex (cis) Toll-like receptor 4:Lymphocyte antigen 96 complex |
ASTN2b |
rs1159787 9:120,327,400 |
7.6×10-11 |
|
|
449 Top |
RANTES (cis) C-C motif chemokine 5 |
CCL5abc, C17orf50ae, RDM1ae, LYZL6ae, TAF15a [3 more]MMP28a, HEATR9a, CCL23b |
rs4239252 17:34,163,565 |
7.8×10-11 |
|
diagnosis, efficacy, unspecified application |
450 Top |
MED-1 (trans) Mediator of RNA polymerase II transcription subunit 1 |
PTCRAabe, RPL7L1ac, C6orf226ac, GLTSCR1La, CNPY3a [4 more]CUL9b, PRPH2b, PTK7b, PEX6c |
rs9462846 6:42,861,581 |
8.1×10-11 |
|
|
451 Top |
Kallistatin (cis) |
|
rs10135681 14:95,007,744 |
8.4×10-11 |
|
|